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Members of the β-CASP family of proteins are involved in DNA 
repair and RNA processing. We identified a member of this family of 
enzymes, hSNM1B/Apollo, in complex with the telomere binding proteins 
TRF2/Rap1. Due to its low abundance at telomeres, we consider Apollo to 
be a telomere accessory factor, and not part of the core telomere protein 
complex, shelterin. Apollo localizes to telomeres by interacting directly with 
the TRFH domain of TRF2. Structural analysis of this interaction revealed 
an interface in the TRFH domain of TRF2 that is predicted to be shared by 
numerous accessory factors recruited to the telomere by TRF2, in addition to 
Apollo.  
 Disruption of the Apollo-TRF2 interaction by expressing an allele of 
Apollo that cannot bind to TRF2 (ApolloΔTRF2) or reducing the amount of 
endogenous Apollo in cells by RNAi resulted in deprotection of telomeres in 
S-phase, as evidenced by the presence of Telomere-dysfunction Induced 
Foci (TIFs). Additionally, Apollo-deficient telomeres have an aberrant 
signal seen by FISH that is more frequent after treatment with the DNA 
 
 
replication inhibitor, Aphidicolin. Together, the data are consistent with a 
role for Apollo during of after telomere replication.  
Isolation of the Apollo protein complex revealed that soluble Apollo 
is complexed in 1:1 stoichiometry with TRF2/Rap1, suggesting that Apollo 
might function primarily at telomeres. Additional components include DBC-
1, which interacts directly with Apollo and localizes to Cajal bodies, the 
translesion synthesis polymerase polη, and the homolgous recombination 
factor Rad51. The association of these proteins with Apollo suggests 
potential roles for Apollo in telomerase recruitment and formation of the 
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CHAPTER 1: INTRODUCTION 
Telomere Structure 
 With the advent of linear chromosomes came the ability to exchange 
genetic information in meiosis. However, a new problem arose, that of 
maintaining chromosome ends, or telomeres. One challenge of replicating 
linear chromosomes is referred to as the "end replication problem" and was 
first described by Watson in 1972 1. Short RNA primers are used by DNA-
replication machineries to initiate DNA synthesis. Removal of the terminal 
primer at the end of lagging strand synthesis leaves a small gap that cannot 
be filled in. Loss of terminal sequences with each round of DNA replication 
will occur if this gap is not compensated for. A second challenge of 
maintaining linear chromosomes is that cells must be able to distinguish 
between double and single stranded DNA at natural chromosome ends and 
sites of DNA damage. Telomeres of diverse organisms have managed to 
solve these problems.  
Repeats 
 Telomeres of most eukaryotic organisms are consist of tandem G-rich 
repeats. The first telomeres to be sequenced were those of linear rDNA from 
Tetrahymena thermophila, which revealed 20-70 repeats of the sequence 
TTGGGG 2. The telomeres of other organisms contain a variation of this 
sequence. One version of telomeric repeat, TTAGGG, is found in such 
dissimilar organisms as acellular slime molds, Trypanosomes, and 
vertebrates. The similarity of chromosome end sequences across a diverse 
set of organisms suggests a common mechanism for preserving chromosome 
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ends.  Telomere sequences have a defined orientation in that the G-rich 
strand always runs 3' to 5' from the end towards the centromere.  
 The number of simple telomere repeats at chromosome ends varies 
dramatically across organisms. The Oxytricha micronucleus can contain as 
little as 20 bp of repetitive DNA . Human telomeres have 5-15 kb of 
TTAGGG repeats 3 4 5, laboratory mouse telomeres are 50-150 kb in length 
6, and chicken telomeres are 10 kb-1 Mb in length 7. Within a cell, the 
amount of telomeric DNA varies from telomere to telomere, resulting in a 
smear when terminal restriction fragment analysis (TRF) is performed.  
3' overhang 
 A 3' overhang on the G-rich strand is a common feature of telomeres. 
The predicted products of DNA replication of a linear chromosome would 
be a molecule with one blunt end (the product of leading strand synthesis) 
and an end with a short 5' overhang (the product of lagging strand synthesis). 
The presence of a 3' overhang on both ends of a chromosome indicates that 
telomeres are processed by a nuclease after DNA replication. This 
processing event might be required to create a substrate for telomere 
extension by telomerase or to generate a substrate for proteins to bind to 
protect the ends of chromosomes. The gap left by removal of the last RNA 
primer in lagging strand synthesis is predicted to be 8-12 nucleotides long. 
Human telomeres lose 50-150 bp/end/cell division, suggesting active 
degradation of chromosome ends. The mechanism and the nucleases 
involved in the attrition of human telomeres are not known. 
The sequence of the 5' end of human chromosomes is precisely defined 
where the majority of human chromosome ends terminate with CCAATC-5' 
8. The 5' end sequence in ciliates is also extremely specific; the C-rich strand 
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in Euplotes always ends in AACCCC-5' and in Tetrahymena the end 
sequence is either CAACCC-5' or CCAACC-5'. The 3' G-rich strand end 
sequence is more precise in ciliates than in human cells 9 10.  
 
Figure 1-1: Chromosome ends form t-loops. 
(A) Schematic identifying different aspects of a t-loop. (B) Electron micrograph depicting 
a t-loop isolated from mouse liver{Griffith et al., 1999, Cell, 97, 503-14.}.  
 
T-loops 
 The 3' overhang in many organisms is concealed by the formation of a 
telomeric loop structure, or t-loop, at chromosome ends (Fig. 1-1). T-loops 
were first observed by electron-microscope analysis of purified, naked 
telomeric DNA from mouse and human cells 11. T-loops are formed through 
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strand invasion of the 3' G-rich overhang into the double-stranded part of the 
telomere. This creates a displacement loop (D loop) of about 150 nt as 
discerned from coating with E. coli single strand binding protein (SSB); 150 
nt is consistent with the average length of the 3' overhang in human cells. T-
loops appear to be a solution that many organisms have adopted as they can 
be detected in Oxytricha, trypanosomes, and plants 12 13 14. Most recently, t-
loops have been isolated in their native chromatin context from chicken 
erythrocyte and mouse lymphocyte nuclei 15. The steps required to form a t-
loop parallel the initial steps of homologous recombination.  Recruitment of 
the homologous recombination machinery to telomeres has been proposed to 
shape the t-loop structure 16. However, this process would have to be tightly 
controlled to prevent inappropriate resolution of the t-loop.  
 
Telomere maintenance by telomerase  
 An activity that could extend GT rich primers was isolated from 
Tetrahymena extracts. This activity was termed telomerase and was 
characterized as a ribonucleoprotein complex whose RNA and protein 
components were both required for activity17 18. Most organisms use 
telomerase to maintain the ends of their chromosomes.  
 Generally, telomerase consists of a reverse transcriptase, an RNA 
template and accessory factors that are not required for catalytic activity of 
the enzyme and instead potentially regulate recruitment to telomeres. The 
single stranded G-rich overhang provides a primer for telomere repeat 
addition to chromosome ends by active telomerase. After elongation of the 
G-rich strand, C-strand synthesis is presumed to occur to generate double 
stranded DNA. DNA polymerases α and δ, along with primase, are required 
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for telomere elongation by telomerase in budding yeast {Diede and 
Gottschling, 1999, Cell, 99, 723-33}. This data indicates that telomerase 
needs to interact with lagging strand DNA synthesis machinery to be active 
and that these two processes, elongation by telomerase and C-strand 
synthesis, might be coordinated. Telomerase needs to be active in unicellular 
eukaryotes to permit further generations. Telomerase is active in human 
germline tissues and in a high percentage of tumors20. However, in the 
human soma, telomerase is repressed by limiting hTERT transcription, as 
hTERC is ubiquitous 21 20.  
 
 
Figure 1-2. Human telomerase. 
Human telomerase is depicted as a dimer with two components of each hTERT,  hTERC, 
and dyskerin.  
 
 Purified catalytically active human telomerase was found to have two 
copies of each hTERT, hTERC, and Dyskerin 22  (Fig. 1-2). A mutation in 
the RNA binding protein Dyskerin is associated with a rare X-linked 
disease, dyskeratosis congenita (DKC) 23. Dyskerin is predicted to be 
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important for the stability of hTERC as patients with mutated dyskerin have 
5-fold less hTERC than unaffected siblings 23. Additionally, autosomal 
dominant forms of DKC exist that are due to mutations in hTERC or 
hTERT. These genetic observations are consistent with a role for dyskerin in 
telomerase function 24. The phenotypes of this disease include defects in 
highly regenerative tissues such as skin and blood and most patients die of 
bone marrow failure. Furthermore, DKC patients have shorter telomeres and 
exhibit chromosome instability 23 25.  
Other strategies to maintain telomere integrity 
 Most telomerase negative human tumors maintain their telomeres by a 
mechanism termed Alternative Lengthening of Telomeres (ALT) 26 27. This 
process relies on telomere-telomere recombination events leading to 
telomeres of extremely heterogeneous lengths compared with related non-
ALT cells 27 28 29. ALT-associated PML bodies (APBs) are present in cells 
that maintain their telomeres by an ALT mechanism 27. APBs contain 
proteins involved in recombination as well as the telomere binding proteins 
TRF1 and TRF2 30. Budding yeast telomeres can also be maintained by 
recombination-based pathways in the absence of telomerase, termed survivor 
pathways 31.  Survivor pathway Type I relies on Rad51p whereas the Type II 
survivor pathway is Rad50p dependent 32 33. Recombination-based telomere 
length maintenance cannot occur in the absence of both of these proteins 33.  
 
Senescence 
 Replicative senescence was first reported by Hayflick and Moorhead 
in 196134. In their experiments, normal diploid fibroblasts stopped dividing 
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in spite of growth in optimal conditions indicating that normal cells have a 
finite capacity to replicate. Olovnikov hypothesized that shortening of 
chromosome ends with each round of replication might explain Hayflick’s 
observation35. The sequencing of telomeres permitted TRF analysis and the 
comparison of telomere length. It was observed that telomeres shorten as 
cultured human fibroblasts divide 5 36 37 38. Definitive proof for the 
relationship between telomere shortening and cellular senescence came 
when the ectopic expression of telomerase prevented the onset of replicative 
senescence in human primary fibroblasts 39.   
Human telomere binding proteins – Shelterin 
 Shelterin is a specialized six-member protein complex found at human 
telomeres. The individual components that make up shelterin are TRF1, 
TRF2, Pot1, Tin2, TPP1 and Rap1 (Fig. 1-3). Shelterin is required for the 
protection of telomeres from the DNA damage response and for telomere 
length regulation40. TRF1 and TRF2 bind directly to double stranded 
TTAGGG repeats as homodimers, engaging DNA with two Myb domains 41 
42 43 44 45. Pot1 binds to single stranded DNA with OB-folds 46 47. Tin2 makes 
contact with and stabilizes TRF1, TRF2, and TPP1. TPP1 acts as a bridge 
between Tin2 and Pot1. Rap1 binds to TRF2 48 49 50 51 52. Shelterin can exist 
as a single complex or in subcomplexes containing TRF1 or TRF2 and their 




Figure 1-3. Shelterin binds to mammalian telomeres.  
(A) Schematic of shelterin on telomeric DNA. For simplicity, POT1 is only shown as 
binding the site closest to the duplex telomeric DNA although it can also bind to the 3' 
end. (B) The six known subunits of shelterin, their domain structure, protein interactions, 
and DNA-binding sites. 
 
TRF1 
The first shelterin component to be identified was TRF1 based on its ability 
to bind to TTAGGG repeats 42.  
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TRF1 has an N-terminal acidic domain, a homodimerization domain 
(TRFH), a hinge domain, and a C-terminal DNA binding Myb domain. 
TRF1 binds to double stranded telomeric DNA as a homodimer. Each Myb 
domain binds one 5'YTAGGGTTR3' half site. The length of DNA between 
bound Myb domains from a single TRF1 homodimer can vary indicating 
flexibility in the hinge domain 43 54. TRF1 is a negative regulator of telomere 
length. Overexpression of TRF1 in a clone of the human tumor cell line 
HT1080 results in telomere shortening. Removal of TRF1 from telomeres by 
the expression of a dominant-negative allele results in the lengthening of 
telomere tracts 55 56 57. It was concluded that TRF1 affects the telomerase 
pathway as overexpression of TRF1 in telomerase negative cells did not 
affect the shortening rate 58. Mouse knockout experiments showed that TRF1 
is an essential gene suggesting a role beyond telomere length regulation 59.  
TRF2 
 TRF2 was discovered by searching the human gene database for TRF-
like proteins 41 44. TRF2 and TRF1 have the same domain layout with one 
major difference: TRF2 has an N terminal basic domain whereas the N-
terminus of TRF1 is acidic. Like TRF1, TRF2 binds to double stranded 
DNA as a homodimer 41. In spite of the near identical three-dimensional 
structure of the homodimerization domains (TRFH) of TRF2 and TRF1, 
they cannot form heterodimers due to steric constraints 60. In contrast to 
vertebrates, fission yeast contain only one TRF factor, Taz1 61. Like TRF1, 
TRF2 has a role in telomere length regulation. The telomeres of human 
primary fibroblasts that overexpress TRF2 shorten faster than telomeres 
from cells expressing TRF1. There is no change in the length of the G-rich 3' 
overhang in TRF2 overexpressing cells, eliminating the possibility of 
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increased shortening due to enhanced 5' resection. TRF2 binding to 
telomeres is indispensable for telomere protection. The details of this role 
are discussed below.  
Rap1 
 Human Rap1 was discovered in a two-hybrid screen for TRF2-
interacting proteins. The C-terminus of Rap1 binds to the TRFH and hinge 
domains of TRF2 62. In a pulldown experiment with endogenous TRF2, 
Rap1 was found in 1:1 stoichiometry with TRF2 16. Heterodimerization with 
TRF2 is essential for Rap1 protein stability, as evidenced by decreased Rap1 
protein levels in TRF2 deleted cells 63. In contrast to budding yeast 
ScRap1p, hRap1 does not directly bind to telomeric DNA 62. ScRap1 
engages DNA with two Myb domains, whereas the single Myb domain of 
hRap1 is predicted to mediate protein-protein interactions 64 65. The fission 
yeast Rap1 ortholog also cannot bind telomeric DNA directly and is 
dependent on the TRF-like factor, Taz1 for localization to telomeres 66. The 
function of Rap1 has not been fully established. Rap1 is an essential gene in 
mice, suggesting a role in telomere protection (van Overbeek and de Lange 
unpublished results). Rap1 also contributes to telomere length regulation 
since the expression of an allele lacking the N-terminal BRCT domain of 
Rap1 leads to a reduction in telomere length heterogeneity 67. 
Pot1/TPP1 
 The first telomere-specific binding proteins to be discovered, 
Telomere End Binding Protein (TEBP) α/β, were isolated from Oxyticha 
nova macronuclear DNA 68. To bind effectively to telomeres TEBP α/β 
require both the 3' G-rich overhang and the adjacent duplex DNA. The 
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crystal structure of TEBP α/β in complex with telomeric DNA revealed that 
these proteins use three oligosaccharide/oligonucleotide-binding (OB) folds 
to bind to single stranded DNA and a fourth to interact with each other 69.  
 Schizosaccharomyces pombe Pot1 (protection of telomeres) was 
identified by homology to the OB-fold containing N-terminus of TEBP α 46. 
Deletion of SpPot1 results in rapid telomere degradation and senescence. 
The surviving S. pombe cells have circular chromosomes. Further searches 
for OB-fold containing proteins using the N-terminus of SpPot1 in human 
databases identified human Pot1 46.  
 hPot1 binds specifically to single-stranded telomeric DNA 70 71. The 
overexpression of hPot1 lacking its N-terminal OB-fold results in rapid 
telomere elongation, suggesting that hPot1 can act as a negative regulator of 
telomere length 47. IF and ChIP analysis revealed that Pot1ΔOB still 
localizes to telomeres presumably through a protein interaction within 
shelterin {Loayza and de Lange, 2003, Nature, 424, 1013-8}. This 
interaction is mediated by TPP1 {Ye et al., 2004, Genes Dev, 18, 1649-54} 
{Hockemeyer et al., 2007, Nat Struct Mol Biol, 14, 754-61}.  
 TPP1 was discovered in biochemical experiments that searched for 
Tin2 and Pot1 interacting factors 50 72 51. TPP1 serves as a bridge between 
Tin2 and Pot1 and is required for Pot1 localization to telomeres 50 51 72. 
Recent structural and functional studies have shown that Pot1 and TPP1 are 
equivalent to the TEBP α/β complex in O. nova 73 74.  
Tin2 
 Tin2 was identified in a yeast two-hybrid screen using TRF1 as bait. 
In this study, the C-terminus of Tin2 was shown to bind to the TRFH 
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domain in TRF1 75. Further studies have demonstrated that Tin2 can bind 
TRF1 and TRF2 simultaneously 48 49. Disruption of Tin2 results in 
destabilization of TRF1 and TRF2 at the telomere and a DNA damage 
response at telomeres 48 49. Structural analysis of the interaction of the C-
terminus of Tin2 with TRF1-TRFH identify the interaction interface as 
Tin2256-276 and a loop between alpha helix 3 and 4 in TRF1-TRFH 76. TRF2-
TRFH does not mediate a stable interaction with Tin2. Instead, the N 
terminus of Tin2 binds to a short motif in the hinge domain of TRF2 76. Tin2 
is also required for the localization of TPP1 to telomeres 72 51 50 and through 
TPP1 the localization of Pot1 to the telomere. Through its multiple 
interactions, Tin2 is able to stabilize shelterin on telomeres.  
Telomere Protection Mediated by TRF2  
TRF2 prevents NHEJ at the telomere 
 Removal of TRF2 from the telomere, either by expression of a 
dominant negative allele or by genetic ablation in the mouse, leads to a DNA 
damage response at telomeres and fusion of telomere ends to each other 77 45 
63. Preceding the fusion event, the G-rich 3' overhang is removed by the 
XPF/ERCC1 nuclease 78. Fusion events can not occur in the absence of 
Ligase 4 and Ku70, implicating NHEJ in the reaction 79 63 80. In cells with 
defective NHEJ, deprotected telomeres can still recruit DNA damage factors 
in discrete foci that co-localize with telomeres. These foci are called 
Telomere-dysfunction Induced Foci (TIFs). TIFs contain phosphorylated 
histone H2AX (γ-H2AX), 53BP1, phosphorylated Rad17, ATM 
phosphorylated on S-1981, Mre11, Nbs1 and MDC1 77 81. The formation of 
TIFs after removal of TRF2 is dependent on ATM 77 82.  
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 Depending on the cell type, TRF2 deficiency either results in 
senescence or apoptosis 83 45. The senescence induced by TRF2 removal is 
similar to cells that enter into replicative senescence. In TRF2 deficient cells, 
p53 levels are stabilized, p21 and p16 levels are induced, and cells stain 
positive for SA-β-galactosidase 45 77. Cells that overexpress TRF2 senesce 
with shorter telomeres than cells with wildtype levels of TRF2 58. These 
experiments suggest that senescence is induced by the inability of short 
telomeres to load a sufficient amount of TRF2 rather than by chromosome 
ends that lack telomeric DNA. What is the minimum length of a human 
telomere that can still be protected by TRF2? Senescence can be bypassed in 
cells by the expression of human papilloma virus (HPV) oncoproteins E6 
and E7 which abrogates the function of p53 and Rb, respectively 84. 
Experiments using single telomere length analysis (STELA) on DNA from 
MRC5 cells driven into crisis by the expression E6 and E7 suggest that a 
minimum of 12.8 TTAGGG duplex repeats are required to prevent telomere-
telomere fusions 85. Considering that the TRF1 DNA binding half site is 
5'YTAGGGTTR 3', one TRF homodimer needs three repeats to bind to 
telomeres54. This suggests that a minimum of four TRF homodimers bound 
to the telomere is required to prevent telomere fusion.  
TRF2 prevents inappropriate homologous recombination at the telomere 
 An allele of TRF2 lacking its N-terminal basic domain (TRF2ΔB) 
causes senescence and TIFs when overexpressed 86. This allele retains the 
ability to bind to telomeres and prevents telomere-telomere fusions. Further 
investigation revealed that telomere tracts are rapidly lost in cells expressing 
TRF2ΔB as a result of homologous recombination of the t-loop structure. 
Consistent with this model, telomere loss and presumably the formation of 
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telomeric circles is dependent on the Rad51 paralog XRCC3, which has 
been implicated in Holliday Junction resolution 87 86. The basic domain of 
TRF2 may be preventing branch migration of the 5' end into the t-loop 
structure possibly by recruiting a nuclease. If branch migration is not 
prevented, the resulting double Holliday Junction will be a target for 
resolvases producing short telomeres and telomere circles.  
 Other models have been proposed to describe the function of the basic 
domain of TRF2. Griffith and colleagues have shown that the basic domain 
of TRF2 can bind directly to DNA junctions and in this capacity might 
stabilize t-loops {Fouche et al., 2006, J Biol Chem, 281, 37486-95}. 
Consistent with this finding, work from the Gilson lab has shown that the 
basic domain of TRF2 makes direct contact with DNA in a structure and not 
a sequence specific manner and is expected to be important for making the 
appropriate contacts that would stabilize t-loops {Amiard et al., 2007, Nat 
Struct Mol Biol, 14, 147-154}.   
 Processes similar to t-loop HR have been identified in other 
organisms. T-loop resolution by homologous recombination is suppressed 
by Ku in Arabadopsis thaliana 88. A deletion process termed Telomere 
Rapid Deletion (TRD) in yeast occurs where up to several kilobases of 
telomeric DNA is lost in a single step89 90. The mechanisms behind TRD and 
t-loop HR might be similar.  
 The formation of the protective t-loop structure parallels the first steps 
of interchromatid homologous recombination. HR machinery might be 
required at telomeres to initiate t-loop formation. However, it must be tightly 
controlled by shelterin to prevent recombination of the telomere and 
subsequent shortening of telomeres. Consistent with a positive role of HR at 
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telomeres, Rad54 and the Rad51 paralog, Rad51D, have a role in telomere 
length maintenance and telomere capping 91 92. Also, the MRN complex in 
addition to its roles in HR is thought to act in conjunction with telomerase in 
telomere length maintenance 93. 
How does TRF2 prevent telomeres from being recognized as sites of DNA 
damage?  
 TRF2 could prevent telomeres from being recognized as sites of DNA 
damage in several ways. TRF2 was shown in vitro to stimulate t-loop 
formation 11 94. Secondly, the protection offered by TRF2 could be mediated 
through its binding partners. TRF2 recruits the shelterin factor Rap1 and 
many proteins involved in DNA repair to the telomere including the NER 
nuclease XPF/ERCC1 and the Mre11 complex 62 16 78. The importance of 
Rap1 and TRF2 accessory proteins in mediating the role of TRF2 at the 
telomere is not fully understood. Lastly, TRF2 has been shown to bind to 
ATM, a kinase upstream in signaling the DNA damage response, and to 
inhibit its activation 95. TRF2 might bind to ATM locally at telomeres and 
suppress its activity.   
Telomere length regulation 
 Based on the isolation of catalytically active human telomerase from 
HEK-293 cells it has been estimated that there are only 20-50 molecules of 
telomerase per cell 22. Work in yeast has shown that telomerase does not 
elongate every telomere each cell cycle. Instead, telomerase has a preference 
for telomeres as they become shorter implying that telomeres exist in 
extendible and non-extendible states 96. In an extendible state telomeres must 
be able to recruit telomerase to their ends. In budding yeast, the single 
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stranded binding protein Cdc13p interacts directly with Est1p of yeast 
telomerase 97. A direct interaction between hTERT and the shelterin 
component TPP1 has been reported 74. Additionally, in vitro work has 
demonstrated that telomerase is more processive when TPP1 is bound to 
Pot1 on single stranded DNA compared with Pot1 alone suggesting that 
TPP1 can stabilize telomerase 73.  
 The access of telomerase to telomeres is regulated through a negative 
feedback loop in cis by telomere binding proteins. The evidence for this 
mechanism in human cells comes from experiments with TRF1. The number 
of TRF1 molecules/telomere is proportional to telomere length. 
Furthermore, the overexpression of TRF1 leads to shortening of telomeres in 
telomerase positive cells without affecting the intrinsic activity of telomerase 
55. More recent studies have shown that Pot1 mediates TRF1 negative 
regulation of telomerase at the 3' end of telomeres 47. The C-terminus of 
ScRap1p was shown to function in a similar manner to TRF1 in S. cerevisiae 
by targeting experiments98. This role is also consistent for Taz1 at telomeres 
in S. pombe 61. Human Rap1, which cannot bind directly to telomeres, 
negatively affects telomere length 62. It is not known whether Rap1 functions 
in the same pathway as TRF1 or in a parallel pathway.   
 
Replication of telomeres 
 In contrast to the late replication timing of budding yeast telomeres, 
experiments using BrdU labeling show that the telomeres of humans and the 
barking deer (Muntiacus muntjac) replicate throughout S-phase 99 100 101 102. 
The repetitive and G-rich nature of telomeres are predicted to complicate 
replication. G-quadruplex secondary structures have been observed in vitro 
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using double stranded DNA oligos of telomere repeat sequences 103 104 105. 
These structures might form in vivo and act as a barrier to replication. 
Helicases are likely to be required to unwind G-quadruplexes and telomere 
binding proteins might act to prevent the formation of G-quartet structures 
once those strands are unwound. Consistent with this hypothesis, the WRN 
helicase is required for the efficient replication of G-rich telomeric DNA 106. 
Furthermore, TRF2 interacts directly with WRN and has been proposed to 
regulate its telomere specific role 107. Also consistent with the hypothesis 
stated above, Pot1 has been shown to in vitro to disrupt G-quadruplex 
formation 108. Nucleases have also been implicated in the resolution of G-
quadruplex structures in yeast and humans 109 110 111. 
 Taz1 is required for telomere replication in S. pombe. 112 In cells 
without Taz1 replication forks stall at telomere sequences whether they are 
placed internally or at natural chromosome ends. This demonstrates that the 
phenotype is due to characteristics of the telomere sequence and not position 
within a chromosome. Taz1 is predicted to act by either altering the telomere 
complex to allow for replication fork passage or by recruiting helicases to 
manage telomere specific secondary structures.  
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CHAPTER 2: IDENTIFICATION OF SNM1B/APOLLO AS 
A SHELTERIN ASSOCIATED FACTOR 
 This chapter describes the identification of a new shelterin associated 
factor, the SNM1B nuclease part of the β-CASP family of nucleases. 
Shelterin associates with several accessory factors that are distinguished 
from the shelterin core components (TRF1, TRF2, Rap1, TIN2, TPP1, and 
Pot1) based on their lower abundance at telomeres and/or their transient 
association with chromosome ends (Fig. 2-1) 40. Most shelterin associated 
factors have additional non-telomeric functions, contributing to the DNA 
damage response or other chromosomal transactions. The telomeric position 
of these factors creates a paradox, since it is generally assumed that shelterin 
protects telomeres from detrimental reactions mediated by these type of 
proteins.  
 Pulldown experiments of endogenous TRF2 from HeLa nuclear 
extracts have revealed the association of the Mre11/Rad50/Nbs1 complex 
and XPF/ERCC1 with telomeres 16 78. The Mre11/Rad50/Nbs1 complex is 
involved globally in double strand break (DSB) signalling and the repair of 
DSBs through homologous recombination 113 114. Mre11 and Rad50 are 
localized to telomeres in all cell cycle stages whereas Nbs1 is localized to 
telomeres specifically in S-phase. The role of the Mre11 complex at 
telomeres has not been elucidated. In contrast, MEFs deficient for the 
nucleotide excision repair (NER) nuclease, XPF/ERCC1, exhibit telomeric 
DNA containing double-minute chromosomes, which have been proposed to 
be the product of 3' overhang invasion into interstitial telomere related 
sequences. At dysfunctional telomeres, XPF/ERCC1 is required to clip the 3' 




Figure 2-1. Shelterin associated factors.  
Cartoon representation of shelterin associated factors recruited to telomeres via 
interactions with TRF1 and/or TRF2. 
 Other DNA repair factors localized to telomeres include DNA-PKcs 
and the Ku70/86 heterodimer. Both are part of the NHEJ machinery, which 
is normally repressed at telomeres by TRF2 115 116 117. TRF2-/- Ku70-/- 
MEFs exhibit telomere sister chromosome exchanges (T-SCEs), implying 
that Ku can inhibit homologous recombination at telomeres in the absence of 
TRF2 80. This activity might be important to prevent cells from adopting an 
ALT mechanism to maintain their telomeres. For instance, when telomeres 
become shortened as a consequence of replicative attrition, they may contain 




 The WRN RecQ helicase is another example of a factor that binds to 
telomeres and may have positive and negative effects. Individuals with 
mutated WRN display cellular defects associated with telomere maintenance 
such as premature aging and genomic instability. WRN binds to TRF2 and is 
required for efficient lagging strand replication of telomeres.  WRN is 
predicted to act by unwinding G-quadruplex structures at TTAGGG repeats 
that might otherwise impede the replication fork. 107 106. However, WRN can 
also resolve t-loops in vitro using its helicase and 3'-5' exonuclease activities 
by degrading and releasing the 3' overhang 118. If unregulated, WRN might 
cause unscheduled opening of the t-loop.  
 TRF2 interacts with the ATM kinase (based on co-IP experiments) 
and overexpression of TRF2 inhibits autophosphorylation and activation of 
ATM 95. In this capacity, TRF2 might protect telomeres from inappropriate 
processing events by prohibiting the local activation of the ATM pathway at 
telomeres.  
  Several PARPs (Poly(ADP-ribose) polymerases), including PARP-1, 
PARP-2, Tankyrase-1, and Tankyrase-2  associate with telomeres 119. PARP-
1, which interacts with TRF2, binds to DNA breaks and poly(ADP)-
ribosylates proteins involved in DNA repair and chromatin structure. PARP-
1 has been shown to localize to eroded telomeres by FISH and colocalizes 
with TRF2 at damaged telomeres 120. PARP-2 also interacts with TRF2 and 
has been proposed to regulate the binding of TRF2 to telomeres by 
poly(ADP-ribosylation) 121. Tankyrase-1 and Tankyrase-2 both bind to and 
poly(ADP)-ribosylate TRF1 and regulate telomere length by affecting the 
ability of TRF1 to bind to telomeres 122 123 124 125 126 127. Tankyrase-1 also 
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affects sister-telomere cohesion. Cells that lack Tankyrase-1 cannot progress 
through anaphase due to the continued association of their telomeres 128.  
β-CASP family of nucleases 
 The metallo-β-lactamase superfamily is characterized by a highly 
conserved HxHxDH motif that is required for Zn ion coordination and 
necessary for catalytic activity of the enzymes. Enzymes of this family act 
on substrates that have ester linkages and negative charge 129. Members of 
this family include cAMP phosphodiesterases, aryl sulfatases, and nucleases. 
The β-CASP (metallo-β-lactamase-associated CPSF Artemis SNM1/PSO2) 
class of enzymes within the metallo-β-lactamase superfamily act on nucleic 
acid substrates and are involved in DNA repair and RNA processing 130.  
 CPSF-73 (cleavage-polyadenylation specificity factor 73) is an RNA 
endonuclease that cleaves the 3' end of pre-mRNAs to allow for the 
synthesis of a poly(A) tail 131 132. There are three human orthologs of the S. 
cerevisiae inter-strand crosslink (ICL) repair protein SNM1/PSO2 (Sensitive 
to nitrogen mustard 1/Psoralen-UVA sensitive 2), SNM1A, SNM1B, and 
SNM1C (Artemis). Artemis is the most characterized of the β-CASP class of 
enzymes that uses DNA as a substrate. Mutations in human Artemis were 
discovered in patients with RS-SCID (radiosensitive severe combined 
immunodeficiency)133. Artemis is involved in V(D)J recombination 133 134 135 
and is also implicated in non-homologous end joining (NHEJ) of IR-induced 
DNA breaks 136. Artemis-deficient mouse cells are radiosensitive, showing 
an increased level of IR-induced genome instability 137. Although their 
functions have not been fully worked out, both SNM1A and SNM1B have 
been implicated in ICL repair 138 139. SNM1A has been reported to colocalize 
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with Mre11 and 53BP1 at IR-induced breaks, and to physically interact with 
53BP1 140.  
Results 
Biochemistry and isolation of the Rap1/TRF2 protein complex 
 To search for TRF2 and Rap1-interacting partners, FLAG-HA2-Rap1 
was expressed in HeLa S3 cells, and clonal cell lines were isolated (Fig.2-
2A). Rap1 binds to TRF2 with a 1:1 stoichiometry and heterodimerization 
with TRF2 is essential for Rap1 stability 16 63. Two cell lines that expressed 
tagged Rap1 at roughly the same level as endogenous Rap1 (N-terminally 
tagged Rap1-N8 and C-terminally tagged Rap1-C12) and tested for the 
ability of tagged Rap1 to efficiently IP TRF2 were used for affinity 
purification experiments (Fig. 2-2A). Clones N8, C12, and the vector 
expressing cell lines were grown to 10 liters in suspension in high density 
medium [1.5-1.8 x 106 cells/ml] to yield 1.5-1.8 x 1010 cells/experiment. 
Nuclei were isolated from these cells through douncing and soluble nuclear 
proteins were extracted in 420 mM KCl following the method of Dignam et 
al. 141. The Rap1/TRF2 complex was isolated by tandem affinity purification 
using FLAG and HA epitopes, and the isolated proteins were analyzed by 





Figure 2-2. Apollo interacts with the TRF2/Rap1 complex.  
(A) HeLa S3 parental cell lines (above) and examples of clones (below). Clonal cell lines 
used to isolate the TRF2/Rap1 complex are shown in gray boxes (C-terminally tagged 
clone 12, N-terminally tagged clone 8). (B) Tandem purification using tagged Rap1 
FLAG and HA epitopes. Total (T1), Flow through (FT), Washes (W1-W2), Elutions (E1-
2). Immunoblots were probed with anti-Rap1 #765. (C) Immunoblotting analysis of the 
purified TRF2/Rap1 complex. The affinity-purified TRF2/Rap1 complex from HeLaS3 
cells expressing N terminally tagged hRap1 or vector control cells analyzed for the 
presence of hRap1 (765), TRF1 (371), TRF2 (647), or a control nuclear protein (anti-p54) 
is shown. Input (I) lanes contained 0.1% of input lysate, elution (E) lanes contained 2% 
of the eluate. (D) Proteins present in purified TRF2/Rap1 complex. Shown is a silver-
stained gel of the indicated affinity-purified TRF2/Rap1complexes derived from HeLaS3 
cells expressing FHA2-tagged hRap1 (N- or C-terminally tagged as indicated) and 
material derived from vector control cells processed in parallel. Relevant interacting 
proteins that were identified by mass spectrometry and immunoblotting are indicated in 





 The isolated TRF2/Rap1 complex from both N- and C-terminally 
tagged Rap1 contained specific bands that were not present in the vector 
control, indicating that the position of the affinity tag did not interfere with 
our ability to pulldown Rap1 interacting partners (Fig. 2-2D). The 
polypeptides in the FHA2-Rap1 preparations were subjected to mass 
spectrometry analysis using two methods. In collaboration with the Chait lab 
at Rockefeller, the entire lane was sliced into 2 mm pieces, or individual 
bands were cut out and analyzed using the mass spectrometry facility at 
Rockefeller. All bands were trypsin digested and analyzed by MS/MS. We 
found the presence of previously identified TRF2-associated components 
RAD50 and ERCC1 by both methods (Fig. 2-2D). 
 Prior to this study, it was assumed that TRF1 and TRF2 formed 
independent complexes at telomeres where TRF1 and its interacting factors 
were responsible for telomere length regulation and the TRF2 complex was 
responsible for protecting telomeres from the DNA damage response. 
However, in both methods to isolate the TRF2/Rap1 complex, polypeptides 
were recovered from all six shelterin components: TRF1, Pot1, TRF2, Rap1, 
Tin2, and TPP1 (Fig. 2-2C-D). The TRF1/Tin2 complex isolated in a similar 
manner also revealed the presence of all six shelterin components and 
further experiments showed that Tin2 is the lynchpin of these two complexes 
48.  
The putative nuclease hSNM1B (Apollo) identified as part of the TRF2/Rap1 
complex 
 In the course of these experiments, a protein migrating slightly faster 
than tagged Rap1 was reproducibly observed. The identity of this Rap1 
associated protein remained elusive using the Chait lab technique involving 
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slicing the entire gel lane. Therefore, we repeated the isolation of the Rap1 
complex to excise the 60 kDa band for mass spectrometry (Fig. 2-2D). Mass 
spectrometry of the 60 kDa Rap1-associated protein identified six peptides 
from SNM1B (Fig. 2-2E). 
 


















Figure 2-3. SNM1A, SNM1B/Apollo, and SNM1C/Artemis nuclease domains.  
(A) Alignment showing the relative position of metallo-β-lactamase and β-CASP 
domains in SNM1A-C. Numbers correspond to amino acids. The % identity of SNM1A 
and SNM1C relative to SNM1B in nuclease domain indicated. (B) Alignment of the 
metallo-β-lactamase and β-CASP regions of SNM1A, SNM1B/Apollo, and 
SNM1C/Artemis. Residues required for Zn ion coordination and endonuclease activity of 
Aretmis are shown in red boxes. Specific amino acids used for the alignment are shown 
in (A). (C) Alignment of full length Apollo and full length Artemis. Alignments were 













 The nuclease domains of SNM1A, SNM1B, and SNM1C demonstrate 
a great deal of conservation. The metallo-β-lactamase and β-CASP domains 
of SNM1B and SNM1A share 26.6% identity (Fig. 2-3A-B). Artemis and 
SNM1A share 22.5% identity in this conserved region (Fig. 2-3A-B). 
Alignment of the metallo-β-lactamase and β-CASP domains in these three 
proteins reveals a total conservation in Apollo and SNM1A of the residues 
shown to be required for Aretmis endonuclease activity, and are predicted to 
be involved in Zn ion coordination in the metallo-β-lactamase super family 
(Fig. 2-3B shown in red boxes) 142 130. Artemis has roughly the same 
relatedness to SNM1B as it has to SNM1A in its metallo-β-lactamase and β-
CASP domains (25.9% and 22.5% identity, respectively) (Fig. 2-3B). Yet, 
Artemis and SNM1B share a structural similarity in the N-terminal position 
of their nuclease domains, whereas the nuclease domain of SNM1A is C-
terminally positioned (Fig. 2-3A). To emphasize the structural relatedness of 
SNM1B and Artemis, we refer to this protein as Apollo, the twin brother of 
Artemis in Greek mythology. 
 The C-terminus of Artemis is rich in SQ sites, the predicted 
phosphorylation motif for the phosphoinositide-3-OH-kinase-related kinases 
(PIKKs) ATM, ATR, and DNA-PKcs 143 144. Artemis has been shown to be 
phosphorylated by DNA-PKcs on these sites and this phosphorylation 
confers endonuclease activity on Artemis 145. Artemis has also been reported 
to be a phosphorylation target of ATM and ATR 146. These sites are not 
conserved in Apollo (Fig. 2-3C). Human Apollo has four different S/TQ 
sites at residues 349, 364, 418, and 444 (Fig. 2-3C, Fig. 2-4B-C). Only T349 
is conserved in the mouse (Fig. 2-4B-C). An Apollo peptide containing 
phosphorylated SQ344 was isolated from human cells in a screen for 
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proteins phosphorylated by ATM or ATR in response to DNA damage 147. 
This site is conserved only in chimpanzees and not other primates or 
mammals examined and might reflect a unique method of modulating 
human Apollo that is not found outside the great apes (Fig. 2-4C).   
 

















Figure 2-4. Structure, detection, and phosphorylation of SNM1B/Apollo.  
(A) Schematic of human Apollo indicating peptides used for making antibodies, putative 
PIKK phosphorylation sites, nuclease domains, NLS, and exon structure. (B) Alignment 
of human, mouse, and chicken Apollo showing divergence in C-terminus and lack of 
conservation of S/TQ sites. Nuclease domains and NLS are boxed in red. 
Phosphorylation sites in human Apollo are indicated with (*). (C) Alignment of  putative 
PIKK phosphorylation sites in mammalianApollo homologs. Putative phosphorylation 














 The C-terminal part of the β-CASP motif in Apollo contains an RNA 
metabolizing motif that is also found in SNM1A but not Artemis (Prosite 
motif Scan) (Fig. 2-4A). The genomic structure of Apollo has four exons 
(Fig. 2-4A).  Human and mouse Apollo have two splice variants, one 
containing all four exons and one lacking exon 2. The latter mRNA has a 
frameshift into an alternative reading frame in exon 3 that ends with a stop 
codon at amino acid 72. This form of Apollo is predicted to be 8.2 kDa and 
to only contain a portion of the metallo-β-lactamase domain and no NLS.  
Apollo interacts with TRF2  
The association of Apollo with shelterin was verified based on recovery of 
endogenous shelterin components in immunoprecipitates (IPs) of transiently 
transfected Myc-tagged Apollo in 293T cells. Myc-Apollo brought down 
TRF2 and Rap1 but not TIN2 or TRF1 (Fig. 2-5A). IPs of Apollo co-
transfected with individual shelterin components showed an association of 
Apollo with TRF2 and Rap1, whereas the recovery of Apollo in association 
with TRF1, TIN2, and POT1 was minimal (Fig. 2-5B). In order to determine 
whether Apollo could associate with TRF2 and to what extent Rap1 
contributed to the interactions, we co-transfected Apollo with several TRF2 
truncation alleles. These experiments indicated that Apollo can associate 
with the TRFH (TRF homology) 41 60 region of TRF2, which is a protein-
protein interaction domain that mediates homodimerization of TRF2 (Fig. 2-
5C,E). Since the TRFH domain is not sufficient for the interaction of TRF2 
with Rap1 62, these results imply that the Apollo-TRF2 interaction is likely 
to be Rap1 independent. The co-IP of Apollo and Rap1 (Fig. 2-5A-B) is 
probably due to the efficient association of Rap1 with endogenous TRF2. In 
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the course of these experiments, we also found that Apollo had the ability to 
interact with itself, resulting in co-immunoprecipitation of Myc-tagged and 
HA-tagged Apollo (Fig. 2-5D). These results suggest that Apollo associates 
with shelterin through an interaction with TRF2.  
 

















Figure 2-5. Apollo interacts with the TRFH domain of TRF2.  
(A) Interaction of Apollo with endogenous TRF2 and Rap1, but not TIN2 or TRF1. 293T 
cells were transiently transfected with pLPC-Myc-Apollo and immunoprecipitations (IP) 
were performed with the Myc antibody 9E10. IPs were analyzed by immunoblotting for 
the proteins indicated at the right, using the following Abs (top to bottom): 647, 765, 864, 
371, and 9E10. For panels A-D lanes marked In represent 2.5% of in the input lysate used 
for the IPs.(B) Co-IP of Apollo with co-transfected TRF2 and Rap1. 293T cells were 
transiently transfected with the indicated pLPC constructs and IPs were performed with 
the 9E10 Myc antibody (left) or an HA antibody (HA.11) (right). IPs were analyzed by 
immunoblotting (IB) for protein expression (top), and for interaction with Apollo 
(bottom) using the indicated antibodies.(C) Apollo interacts with the TRFH domain of 
TRF2. Myc IPs of extracts from 293T cells transfected with the indicated constructs were 
immunoblotted with the Myc antibody to detect TRF2 alleles and the HA antibody to 
detect Apollo. The TRF2 domains referred to above the lanes (FL: full length) and the 
ΔN version of Apollo are shown in panel E.  (D) Apollo interacts with itself.  293T co-
transfection experiments were as in panels B and C with the indicated constructs. 
Antibodies used for IP and IB are indicated. (E) Schematic of the interaction between 
Apollo and TRF2. B, basic domain. TRFH, TRF homology domain. MYB, Myb-type 













Structural analysis of the Apollo-TRF2 interaction 
 The extreme C-terminus of Apollo (aa 496-532) is required for 
interaction with the TRFH domain of TRF2 148. The Lei lab (University of 
Michigan) tested the binding strength of this interaction using isothermal 
titration calorimetry (ITC).  Apolloaa 496-532, refered to as ApolloTBM, binds to 
the TRFH domain of TRF2 with a Kd of 0.12 µM, whereas no binding 
enthalpy was observed under the same conditions between Apollo and the 
TRFH domain of TRF1 (Fig. 2-6A). The structures of the TRFH domains in 
TRF1 and TRF2 are almost identical 60. To understand how Apollo interacts 
specifically with TRF2 and not TRF1, the TRFH domain of TRF2 was co 
crystallized with Apolloaa498-509 (Fig. 2-6B-C). Residues L500 and Y504 in 
Apollo make key interactions with TRF2-TRFH, whereas these residues are 
occluded from interacting with TRF1-TRFH (Fig. 2-6D, Fig. 2-7A). Tin2 
can bind to the same molecular surface on TRF2-TRFH as Apollo. However, 
Tin2 binds weakly to TRF2-TRFH (Kd of 6.5 µM) and strongly to TRF1-
TRFH (Kd of 0.31 µM). Comparison of these structures revealed that 
Tin2F258 lacks the ability to make electrostatic interactions that 
ApolloY504 makes with TRF2-TRFH in the equivalent position (Fig. 2-6E, 
Fig. 2-7A). From this comparison arose the putative TRF1-TRFH and 




Figure 2-6. Structural analysis of the Apollo-TRF2 interaction.  
(A) In vitro ITC measurements of the interactions of TRF2-TRFH and TRF1-TRFH with 
wild type and mutant Apolloaa496-532 peptides. (B) Overall structure of the dimeric 
TRF2-TRFH/Apolloaa496-532 complex. TRF2-TRFH and Apolloaa496-532 are colored 
in blue and orange, respectively. Schematic of TRF2 above indicating position of F120 in 
the context of the full length protein. (C) TRF2-TRFH/Apolloaa496-532 interface. 
Residues mutated in Apollo for co-IP experiments are boxed. Above, schematic of 
Apollo indicating positions of L506 and P508 in the context of the full length protein. (D) 
Overlay of TRF1-TRFH structure with Apollo peptide showing the occlusion of Apollo 
residues L500 and Y504. (E) Hydrophobic and electrostatic interactions of Apollo Y504 
in context of the TRF2-TRFH domain (left). Hydrophobic pocket showing Tin2 F258 
interaction in the context of the TRF1-TRFH domain. Above experiments were 
performed by Yong Chen and Ming Lei, University of Michigan {Chen et al., 2008, 




 Based on this structure, mutation of F120 in the TRF2-TRFH domain 
in a loop between alpha helix 3 and 4 was predicted to abolish interaction 
with Apollo. Apollo residue L506 fits into a hydrophobic cleft in TRF2 and 
P508 stacks with F120 in the TRFH domain of TRF2 (Fig. 2-7A). Mutation 
of these residues in Apollo is expected to abrogate interaction with TRF2. I 
mutated Apollo at the residues predicted to be required for Apollo binding to 
the TRFH of TRF2 and tested the ability of this point mutant to co-IP with 
TRF2. As shown in previous co-IP experiments, Apollo robustly interacts 
with TRF2 and TRF2ΔB (Fig. 2-7B). In agreement with the structure 
predictions, TRF2ΔB-F120A did not co-IP with Apollo and Apollo-
L506EP508A (from here on referred to as ApolloΔTRF2) did not co-IP with 




Figure 2-7. Apollo L506E P508A does not bind to TRF2. 
(A) Linear representation of Apollo residues aa499-509 and the contacts they make with 
the TRFH domain in TRF2. (B) Apollo L506E P508A (ApolloΔTRF2) disrupts binding 
to TRF2. Co-IP of HA-Apollo and HA-Apollo L506E P508A with co-transfected myc-
TRF2 and myc-TRF2 F120A. 293T cells were transiently transfected with the indicated 
pLPC constructs and IPs were performed with the 9E10 Myc antibody. IPs were analyzed 
by immunoblotting (IB) with the 9E10 Myc antibody for protein expression (bottom), 
and for interaction with Apollo (top-short exposure, middle-long exposure) with the 
HA.11 antibody. (C) Co-IP as in (A) with Myc-TRF2 and HA-Apollo mutated at a 
putative CDK1 site.(D) List of proteins that contain the YxLxP TRF2-TRFH interaction 
motif and the FxLxP TRF1-TRFH interaction motif. 
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Apollo has a putative CDK1 site in its TRF2 localization motif 
 Apollo has a potential CDK1 site (TP) within the TRF2 binding motif 
(CDK1 consensus site S/TPxK). Although tagged Apollo localizes to 
telomeres in a cell cycle independent manner, the possibility that 
endogenous Apollo might be cell cycle regulated cannot be excluded. Based 
on the TRF2-Apollo structure, phosphorylation of T507 in Apollo would 
increase the binding of Apollo to TRF2. Apollo T507 was mutated to T507D 
(phosphomimetic) and to T507A (abrogating phosphorylation) and the 
interaction of these mutants with TRF2 was examined in co-IP experiments. 
Inconsistent with the structure predictions, both the T507D and T507A 
largely abolished binding with TRF2. These mutations might destabilize the 
interaction of Apollo with TRF2 (Fig. 2-7C). This experiment does not rule 
out the possibility of cell cycle regulation of Apollo at telomeres, and it 
remains unclear whether T507 is a phosphorylation site for CDK1. 
Apollo localizes to telomeres 
 To determine whether Apollo can associate with telomeres, we 
expressed Myc-tagged Apollo in hTERT-immortalized human BJ fibroblasts 
(BJ-hTERT) and determined its localization by indirect immunofluorescence 
(IF). Myc-tagged Apollo showed a homogeneous nuclear staining pattern. 
Extraction of soluble nucleoplasmic proteins with Triton-X-100 revealed 
numerous small Myc-Apollo foci that coincided with TRF1 and Rap1 
signals (Fig. 2-8A), indicating that they represented telomeres. Tagged 
Apollo was also found in small foci that did not co-localize with telomeric 
markers. HA-tagged Apollo also colocalized to telomeres in BJ-hTERT 
using a DNA probe to detect telomeres (CCCTAA)3 (Fig. 2-8B). Z-stack 
images taken of these cells indicate that Apollo localizes to the majority of 
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telomeres in BJ-hTERT cells. To further confirm Apollo's localization to 
telomeres, ChIP experiments were performed on BJ-hTERT cells expressing 
Myc-Apollo. Immunopreciptitation of Myc-Apollo resulted in a small but 
significant enrichment of telomeric DNA (Fig. 2-9A-B). 
 



















Figure 2-8. Tagged Apollo localizes to telomeres.  
(A) Localization of retrovirally expressed Myc-tagged Apollo in BJ-hTERT cells. Apollo 
was detected using the 9E10 Myc Ab (Alexa 488, green). Rap1 was detected with Ab 765 
(RRX, red). TRF1 was detected with Ab 371 (RRX, red). Cells were extracted with 
Triton-X-100 to remove soluble proteins. Top panels: BJ-hTERT cells infected with the 
empty pLPC vector. (B) Localization of retrovirally expressed HA-tagged Apollo in BJ-
hTERT cells. Apollo was detected using HA.11 Ab (RRX, red). Telomeres were detected 











Figure 2-9. Apollo localizes to telomeres by ChIP.  
(A) Telomeric ChIP on BJ-hTERT cells infected with pLPC-vector and pLPC-Myc-
Apollo using the indicated antibodies or pre-serum (PI). Duplicate blots were probed for 
telomeric (TTAGGG) or Alu repeats. (B) Quantification of the data in (A) representing 
per cent TTAGGG repeat DNA recovered in each ChIP. Average duplicate signals 
obtained with total DNA samples were used at 100% value for the quantification.  
 
The localization of Apollo to telomeres is dependent on TRF2 
 To test whether the localization of Apollo to telomeres was dependent 
on its interaction with TRF2, HA-Apollo and HA-ApolloΔTRF2 were 
expressed in BJ-hTERT cells and their patterns were analyzed by FISH-IF. 
As shown previously in Fig. 2-8B, HA-Apollo expressing cells have a 
punctate pattern that almost completely colocalizes with a probe recognizing 
TTAGGG (Fig. 2-10A). In contrast, HA-ApolloΔTRF2 has a diffuse nuclear 
staining without foci that colocalize with telomeres (Fig. 2-10A). This 
indicates that TRF2 is required for the recruitment of Apollo to telomeres. 
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Apollo vertebrate homologs have a strong conservation of this motif in the 
otherwise non-conserved/divergent C-terminus of Apollo (Fig. 2-10B).  
 
Figure 2-10. Apollo L506E P508A (ApolloΔTRF2) does not localize to telomeres.  
(A) Localization of retrovirally expressed HA-tagged wildtype and L506E/P508A double 
mutant of Apollo in BJ-hTERT cells. Exogenous Apollo was detected with HA.11 (RRX, 
red). Telomeres were detected with a TTAGGG-specific FISH probe (FITC, green). 
Vector control top panels. (B) Alignment of vertebrate Apollo homologues to 





 Attempts to detect endogenous Apollo by immunoblotting and IF 
using purified anti-peptide antibodies failed (Fig. 2-11A-C). As these α-
Apollo antibodies detected retrovirally expressed Apollo by IF and in 
immunoblots, the failure to detect the endogenous protein is most likely due 
to its low abundance, which was noted previously for other members of the 
β-CASP family 133 138 139 138 139 (Fig. 2-11B-C). We further tested the 
antibodies by immunoblot using extracts from cells treated with the 
proteasome inhibitor MG-132. HA-Apollo and p53 were stabilized after 
treatment with this drug, but endogenous Apollo was still not detectable 
(Fig. 2-11C). A 60 kDa non-specific band, thought initially to be Apollo, did 
not diminish in extracts of cells treated for five days with an Apollo shRNA 
(UTR) (Chapter 3 Fig. 3-1B) (Fig. 2-11C). To determine whether Apollo 
expression might be limited to certain stages of the cell cycle, HeLa cells 
were synchronized using Aphidicolin and a double Thymidine block. 
Western Blotting for Cyclin B was used to determine the progression of cells 
into mitosis (Fig. 2-11D). The blot probed with anti-Apollo antibodies did 
not reveal any bands that increased in intensity over the course of the cell 
cycle (Fig. 2-11D). Furthermore, I was not able to IP endogenous Apollo or 
TRF2 with these antibodies (Fig. 2-8D). As described in the next chapter, 




Figure 2-11. Apollo peptide antibodies recognize exogenous but not endogenous 
Apollo. 
(A) Location of peptides used to generate Apollo antibodies. Abs 1477 and 1478 were 
generated by injecting two rabbits with P1. Abs 1479 and 1480 were generated by 
injecting two rabbits with P2. (B) IF staining in BJ-hTERT and BJ-hTERT Myc-Apollo 
using Apollo antibodies ab 1477 and ab 1478. (C) Immunoblot of IMR90 extracts treated 
with the proteasome inhibitor MG-132. Luc: Luciferase shRNA, UTR: Apollo shRNA 
targeting 3'UTR, Apollo: pLPC-HA-Apollo. Antibodies as indicated. (D) Immunoblot of 
synchronized HeLa cell extracts. Cell cycle stage and hours post-release as indicated. 
Antibodies: Cyclin B (Santa Cruz), Apollo Ab 1477. (E) HeLa cell extracts were 
immunopreipitated with the antibodies indicated at top (Ab 1477, Ab 1478, Ab 1480 all 




Apollo does not localize to sites of DNA damage 
 We investigated whether Apollo relocalizes to sites of damage. After 
exposure to a wide range of DNA damage inducing insults, the localization 
of HA-Apollo at telomeres remained unchanged (Fig. 2-12A). Furthermore, 
in contrast to what has been reported for SNM1A, a general re-localization 
of HA-tagged Apollo to sites of DNA damage (marked by γ-H2AX foci in 
our experiments) was not observed (Fig. 2-12A). The effect of DNA damage 
on HA-Apollo, TRF2, and TRF1 protein levels was tested by 
immunoblotting. IR and UV-induced damage did not have an effect on the 
levels of these proteins. However, TRF2 protein levels increased in cells 
treated with the DNA replication inhibitors Hydroxy Urea, and Aphidicolin 
as well as inter-strand crosslink-inducing drugs cisplatin and MMC (Fig. 2-
12B). Cells treated with these drugs will accumulate in S-phase and will 
therefore have an increased protein concentration compared with cycling 
cells. Considering this, TRF2 levels are still increased by comparison with 
TRF1 and Apollo protein levels. HA-Apollo levels are mildly increased in 
response to cisplatin (Fig. 2-12B). As expected, Chk2 is phosphorylated in 
response to IR and Chk1 is phosphorylated in response to UV, replication 





























Fig. 2-12. Apollo does not relocalize to from telomeres to sites of DNA damage.  
(A) Localization of retrovirally expressed HA-Apollo in BJ-hTERT cells after the 
indicated treatments (left). TRF1 (#371) and γ-H2AX (upstate) in red (RRX). HA-Apollo 
in green, (Alexa 488). Cells were pre-extracted with Triton-X-100. (B) Immunoblot of 
extracts taken from cells in (A). Antibodies, HA.11, TRF2 (647), TRF1 (371), Chk2 (BD 













 The experiments discussed in this chapter reveal the binding of a 
novel factor at telomeres, the Apollo nuclease. Its low abundance at 
telomeres argues against Apollo being a component of the shelterin core 
complex. Hence, Apollo appears to be one of the shelterin accessory factors 
that are present as low copy number at telomeres and/or have a transient 
association with chromosome ends. 
 The localization of Apollo at telomeres is dependent on TRF2. Apollo 
is recruited to telomeres by interacting with a region around F120 in the 
TRFH domain of TRF2 using a putative TRF2-TRFH interacting motif, 
YxLxP. This motif is found in many known TRF2 interacting proteins, 
including Nbs1, PARP-1, ATM, and XPF. The multimeric organization of 
TRF2 might provide enough binding sites for all of these proteins in a single 
complex. Alternatively, TRF2 might bind to telomere accessory factors in 
discrete subcomplexes. Outside of the YxLxP motif and neighboring 
residues, the C-terminus of Apollo is not well conserved in vertebrate 
homologs (Fig. 2-4B, Fig. 2-7D). 
 Unlike SNM1A, tagged Apollo does not relocalize to sites of damage. 
This might indicate that Apollo performs a dedicated role at telomeres. 
Alternatively, telomeres might act as a sink for Apollo when overexpressed 
and a few molecules of tagged or endogenous Apollo might be sufficient at 
sites of damage and are not detected by IF. TRF2 protein levels are 
stabilized after treatment with replication inhibitors and ICL-inducing agents 
and tagged Apollo levels are increased after treatment with cisplatin. This 
observation suggests a possible role for these proteins in telomere 
replication, as discussed further in Chapter 3.  
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CHAPTER 3: APOLLO IS REQUIRED TO PROTECT 
TELOMERES IN S-PHASE 
Shelterin prevents telomeres from being recognized as sites of damage 
When telomeres become deprotected, proteins involved in DNA 
damage signaling and repair localize to telomeres forming foci called 
Telomere-dysfunction Induced Foci (TIF).  TIFs occur in settings where 
TRF2 and Pot1 are compromised 86 77 63 149 150, and during replicative 
senescence151 when shortened telomeres might lack sufficient shelterin to 
repress the DNA damage response. 
 DNA damage signaling after removal of TRF2 is dependent on the 
ataxia telangiectasia mutated (ATM) kinase 83 77 82. The DNA damage 
response factors 53BP1 and γH2AX no longer localize to telomeres in 
TRF2-/- ATM-/- MEFs. Additionally, ATM deficient human fibroblasts 
show a reduction in apoptosis after treatment with a dominant negative allele 
of TRF2 83. To repress ATM at the telomere, TRF2 might act by restraining 
ATM locally through direct interaction 95. Additionally, TRF2 might hide 
structures that would activate ATM such as the junction where the 5' end 
meets the base of the D loop in a t-loop conformation.  
 Single-stranded DNA in the D loop is another aspect of t-loops that 
may need sheltering. Pot1 binds to ssDNA at telomeres and inhibits 
signaling by the ATM-related Rad3 kinase (ATR) 82. Chk1, the downstream 
effector kinase of ATR, is phosphorylated after Pot1 deletion and Pot1 
deficient MEFs lacking ATR do not accumulate DNA damage response 
factors at telomeres. In response to replication stress, ATR and its associated 
protein ATRIP are loaded onto RPA-coated single stranded DNA 152. Pot1 
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might act to suppress ATR by effectively competing with RPA for binding 
single-stranded telomeric DNA. 
 Telomeres fuse end-to-end in the absence of TRF2 45. Telomere fusion 
events are dependent on ATM and components of the NHEJ repair 
machinery 79 63 80 82. In S. cerevisiae the telomere binding protein Rap1 is 
required to prevent NHEJ at telomeres 153. Rap1 is conserved in vertebrates 
and its localization at telomeres is dependent on TRF2 62. In a biochemical 
assay to test DNA repair by NHEJ, human Rap1 prevents end joining of cut 
telomere-containing plasmid DNA 154. Additionally, Rap1-/- mice show 
embryonic lethality before E10.5, suggesting that Rap1 might be required to 
suppress DNA damage signaling at the telomere (van Overbeek and de 
Lange unpublished results). Further testing using reconsititution experiments 
in TRF2-/- MEFs will be key in understanding the contribution of vertebrate 
Rap1 in preventing inappropriate repair at telomeres. Cells deficient for Pot1 
do not exhibit a substantial amount of fusions 150. However, telomeres fuse 
in an ATR dependent pathway in a Pot1 DKO, TRF2-/- ATM-/- setting 82. 
This provides evidence that ATR can signal in the NHEJ pathway under 
certain conditions.   
 In addition to TIFs and telomere-telomere fusions, other indices of 
telomere dysfunction repressed by shelterin and shelterin associated factors 
include telomere sister chromatid exchanges, which are repressed by Ku80 
in the mouse 155 156 80 , and telomeric DNA containing Double Minute 
chromosomes that may result from invasion of 3' overhang into interstial 




Apollo deficient primary cells have a growth defect 
 To determine the contribution of Apollo to telomere metabolism, 
Apollo transcripts were knocked down using RNAi. Target site algorithms 
were provided by the Whitehead Institute siRNA program 
(http://jura.wi.mit.edu/bioc/siRNAext/home). Off-target effects were 
minimized by excluding shRNAs that had non-Apollo targets based on 
BLAST search (targets shown in Fig. 3-1A). All five shRNAs were found to 
effectively reduce the Apollo mRNA levels as determined by RT-PCR (Fig. 
3-1B). Two of the shRNAs were also tested for their ability to diminish the 
levels of Myc-tagged Apollo expressed from a retroviral construct using an 
Apollo specific antibody that recognizes overexpressed protein (Fig. 3-1C).  
 




















Figure 3-1. Structure, detection, and inhibition of Apollo. 
(A) Schematic of Apollo indicating the PCR primers used for RT-PCR and the target 
sites of the shRNA hairpins used for Apollo knockdown. The RT-PCR strategy detects 
Apollo mRNA with and without inclusion of the indicated alternatively spliced exon. (B) 
Reduction of Apollo mRNA levels resulting from RNAi. RNA derived from cells 
infected with the indicated shRNA encoding retroviruses was processed to detect Apollo 
mRNA and GAPDH mRNA as a control using RT-PCR. The RT-PCR detects two 
versions of Apollo mRNA generated by alternative splicing (Luc, luciferase shRNA). (C) 
Immunoblot showing reduced expression of exogenous Apollo upon introduction of 
Apollo shRNAs H2 and H6. BJ cells were infected with a retrovirus expressing Apollo or 
the empty vector and subsequently infected with the indicated shRNA retroviruses. An 
antibody raised to an Apollo peptide (Ab 1477) was used to detect the overexpressed 












 Primary human IMR90 fibroblasts with diminished Apollo mRNA 
levels showed a clear growth defect (Fig. 3-2A). Within a week of 
introduction of Apollo shRNAs, the cells gradually slowed their 
proliferation and appeared to arrest. Reduced proliferation was also observed 
in BJ and BJ-hTERT cells (Fig. 3-3A-B). The reduced proliferation was due 
to the depletion of Apollo since it was rescued by co-infection with a 
retrovirus encoding a mutated version of Apollo lacking the target site for 
one of the shRNAs (Fig. 3-2B). The knockdown cell lines grew at different 
rates. The cells expressing UTR4 and H8 hairpins grew faster than cells 
expressing the H7, H6, and H2 hairpins, even though the RT-PCR levels 
show a similar knockdown for all of these hairpins. This difference might 
reflect off-target effects of the hairpins or small variations in the residual 
mRNA level not easily detected by RT-PCR. A growth defect was not 
observed when Apollo was down regulated in HeLa cells, consistent with 




Figure 3-2. Diminished Apollo expression in human IMR90 fibroblasts results in a 
senescent-like phenotype. 
(A) Diminished cell proliferation upon inhibition of Apollo. IMR90 cells were infected 
with the indicated shRNA retroviruses and subjected to puromycin selection for three 
days. Subsequently, cells numbers were measured at the indicated time points with day 0 
representing the first day after puromycin selection. (B) Absence of the proliferation 
phenotype of Apollo shRNA H6 in cells that co-express shRNA-resistant Apollo (*H6). 
BJ cells were infected with the indicated shRNA retroviruses and subjected to puromycin 
selection for three days. Subsequently, cell numbers were measured at the indicated time 
points with day 0 representing the first day after puromycin selection. (C) Senescence-
like phenotype of IMR90 cells with diminished Apollo expression. Twelve days after 
selection for the indicated shRNAs, cells were photographed after staining  (37ºC, 
overnight) for SA-β-galactosidase. (D) Induction of p21 upon Apollo inhibition. 
Immunoblot of extracts from the cells shown in (B) at day 5 post-selection. (E) Apollo 
knockdown does not affect TRF2 and Rap1. Immunoblot of extracts from the cells shown 





Figure 3-3. Diminished Apollo expression in human BJ and BJ-hTERT fibroblasts 
and not in HeLa cells results in a senescent-like phenotype. 
(A-B) Diminished cell proliferation upon inhibition of Apollo in BJ and BJ-hTERT cells. 
(C) No growth defect upon inhibition of Apollo in HeLa cells. Cells were infected with 
the indicated shRNA retroviruses and subjected to puromycin selection for three days. 
Subsequently, cells numbers were measured at the indicated time points with day 0 
representing the first day after puromycin selection. Apollo mRNA levels are indicated 
for each of the cell lines below the growth curve. 
 
 The Apollo knockdown cells had a senescent morphology and stained 
positive for SA-β-galactosidase, a marker for senescence (Fig. 3-2C). All 
Apollo shRNAs induced the upregulation of the CDK inhibitor p21, a read-
out for p53 activation. Induction of p16, a second CDK inhibitor implicated 
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in senescence, only occurred with Apollo shRNA H2 and may therefore be 
an off-target effect (Fig. 3-2D). As cells deficient for TRF2 also have a 
senescent phenotype 45 63, we examined the TRF2 and Rap1 protein levels. 
The levels of these proteins were unaffected in Apollo knockdown cells, 
indicating that the senescence was not due to loss of TRF2 (Fig 3-2E).  The 
data indicate that Apollo knockdown can induce a senescent-like phenotype.  
Telomere Dysfunction-Induced Foci (TIFs) in Apollo deficient cells  
 The senescence resulting from Apollo knockdown is consistent with 
cells experiencing a persistent DNA damage signal. Diminished Apollo 
expression enforced by three independent shRNAs resulted in TIFs in ~20% 
of IMR90 cells (Fig. 3-4). The TIFs were obvious based on IF for γ-H2AX 
and 53BP1 and the co-localization of these DNA damage response factors 
with TRF1 (Fig. 3-4A). The median number of TIFs per nucleus was ~12 
(Fig. 3-4C). The TIF phenotype associated with Apollo shRNA H6 was not 
observed if the cells co-expressed the version of Apollo resistant to this 
hairpin (Fig. 3-4E), showing that the DNA damage signal is the result of 
Apollo inhibition. Apollo knockdown also resulted in 53BP1 and γ-H2AX 
foci that were not obviously associated with telomeres, suggesting that 
Apollo is required for global genome integrity as well as telomere 
protection. However, more than half of the DNA damage response foci in 
Apollo knockdown cells were localized at chromosome ends (Fig. 3-4D), 






















Figure 3-4. Induction of a telomere damage signal in cells with diminished Apollo. 
(A) IF showing co-localization of γ-H2AX (top) and 53BP1 (bottom) foci with telomeric 
sites marked by TRF1 in IMR90 nuclei of cells treated with the Apollo shRNAs indicated 
on the left. Cells were processed at day 3 post-selection. (B) Quantification of the 
induction of TIFs by Apollo shRNAs. Cells were processed as shown in panel A and 
TIFs were scored based on co-localization of DNA damage factors with TRF1. The 
bargraph shows the percentage of cells (median and standard deviation based on n=3; 
>100 cells per data point) containing 5 or more TIFs for each of the indicated shRNAs. 
(C) Quantification of the number of TIFs per cell. Bar graph representing data derived 
from images as shown in (A). The percentage of foci co-localizing with TRF1 was 
determined in nuclei with ≥5 TIFs. (D) Quantitative analysis of the fraction of DNA 
damage foci that co-localize with telomeres. Cells were processed as in (A) and (B). For 
each TIF positive nucleus the percentage of foci co-localizing with TRF1 was 
determined. Data from γ-H2AX and 53BP1 IF were indistinguishable and pooled to 
generate the bargraphs.(E) Absence of the TIF phenotype of Apollo shRNA H6 in cells 
co-expressing shRNA-resistant Apollo (*H6). BJ cells were processed as shown in Fig. 
3A and nuclei were inspected for TIFs based on co-localization of γ-H2AX with TRF1. 
The bargraph shows the percentage of cells containing 5 or more TIFs for each of the 




Figure 3-5. Telomere Dysfunction in Apollo knockdown cells occurs in S-phase.  
(A) The experimental time line. IMR90 cells retrovirally infected with control shRNA 
and Apollo shRNAs H2 and UTR were pulsed with 10 µM BrdU for 3 hours, 3 days post 
selection. Cells were fixed and processed for TIF analysis, (B) Cells were stained for IF 
using antibodies to TRF1 (red), 53BP1 (right-green) and BrdU (blue). 
 
 Because the TIFs were only observed in ~20% of the Apollo 
knockdown cells, we asked whether they appeared in a specific stage of the 
cell cycle. Initial experiments suggested that the TIFs arose during or after 
DNA replication. Specifically, we noted that the TIF positive cells often had 
a subset of telomeric signals that appeared as doublets (Fig. 3-4A). This 
pattern suggested that the TIFs occurred in cells that had replicated some, 
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but not all of their telomeres. To test whether the TIFs were more prominent 
in S phase than in G1, we examined cells that had been cultured in the 
presence of BrdU for 3 hours (Fig. 3-5). Very few TIF positive cells lacked 
the ability to incorporate BrdU. The fraction of TIF positive cells that had 
incorporated BrdU was 91% and 83% for the Apollo shRNAs H2 and UTR, 
respectively (n≥150 for each) (Fig. 3-5). Collectively, the data suggest that 
Apollo contributes to the protection of telomeres during or soon after DNA 
replication. FACS analysis of BJ cells expressing hairpins H2 and H6 
revealed an accumulation of cells in G2/M (~29% in knockdown cells 
compared with 18% in control cells and ~17% in cells overexpressing 
Apollo) (Fig. 3-6A-D).  
 
Figure 3-6. Apollo deficient BJ fibroblasts accumulate in G2/M. 
FACS profile of Propidium Iodine stained BJ primary fibroblasts expressing (A) 
luciferase control hairpin (B) FHA2-Apollo (C) shRNA H2 and (D) shRNA H6 with the 
indicated percentages of cells in various stages of the cell cycle. The number of cells is 
represented on the y-axis and the DNA content is represented on the x-axis. 
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Multiple telomere FISH signal in Apollo deficient cells  
 Since knockdown of Apollo induced a DNA damage signal at 
telomeres, we evaluated the status of the telomeric DNA by Flouresence In-
Situ Hybridization (FISH). The analysis of metaphase spreads derived from 
Apollo knockdown cells did not show significant levels of telomere 
aberrations (Fig. 3-7A), including telomere-telomere fusions45, telomeric 
DNA containing Double Minute chromosomes, or extrachromosomal 
telomeric signals. However, we did observe a small but significant increase 
of chromatid ends with two or more distinct telomeric FISH signals instead 
of one (Fig. 3-7A and B). Telomere doublets at single chromatid ends have 
been noted previously in Atm-/- mouse cells, and have been recently 
observed in TRF1-/- mouse cells, and TRF2-/- mouse cells rescued with an 
allele of TRF2 that can no longer bind to Tin2 157 (Agnel Sfeir, Jill Donigian, 
and Titia de Lange, unpublished results). They have also been described to 
occur at low frequency in unperturbed human fibroblasts and other human 
cells (Fig. 3-7B) 158. The nature and origin of these aberrant telomere 




Figure 3-7. Apollo shRNAs increase the occurrence of single chromatid multiple 
telomere signals  
(A) Metaphase spreads illustrating presence of multiple telomere signals at single 
chromatid ends. Metaphase spreads were obtained from BJ-hTERT cells treated with the 
indicated shRNAs and processed for telomeric FISH (FITC, green). DNA was stained 
with DAPI (false colored in red). Arrowheads highlight chromatids with telomere 
multiple/doublet signals. Enlarged images (bottom right) are derived from BJ-hTERT 
cells and BJ cells expressing SV40 large T antigen both treated with Apollo shRNAs. 
Metaphases were harvested at day 3 post-selection. (B) Quantification of telomere 
doublets in BJ-hTERT cells treated with the indicated shRNAs. Metaphases were treated 
as in (A) and examined for the occurrence of double telomeric signals at each chromatid 




ApolloΔTRF2 mutant does not rescue telomere-specific phenotypes and 
partially rescues growth defect 
 A small portion of tagged Apollo localizes to sites other than 
telomeres and ~40% of damage foci in Apollo knockdown cells are not at 
telomeres. To test whether the Apollo knockdown phenotypes were due 
entirely to telomere dysfunction, rescue experiments were performed using 
an Apollo point mutant that cannot bind to TRF2 (ApolloΔTRF2, described 
in detail in Chapter 2). This mutant was expressed in BJ-hTERT and IMR90 
cells where endogenous Apollo was simultaneously knocked down using a 
hairpin that targets its 3'UTR and is absent from the ApolloΔTRF2 construct. 
Neither the TIF phenotype nor the occurrence of multiple telomere signals 
was rescued by the expression of ApolloΔTRF2, whereas wild type Apollo 
fully rescued both phenotypes (Fig. 3-8A, Fig. 3-9A). Interestingly, cells 
overexpressing ApolloΔTRF2 showed TIFs and multiple telomere signals, 
although the phenotypes were less severe (Fig. 3-8A, Fig. 3-9A). This 
indicates that ApolloΔTRF2 may be a dominant negative allele that acts 
either by titrating limiting factors away from the telomere, or by dimerizing 
with endogenous Apollo and preventing it from binding to telomeres. The 
number of TIFs in TIF positive cells expressing both ApolloΔTRF2 and 
shUTR was greater than in cells expressing shUTR alone (Fig. 3-8C). 
Furthermore, TIFs accounted for ~75% of the damage foci in TIF positive 
cells expressing shUTR rescued with ApolloΔTRF2 compared with ~50-
60% in TIF positive shUTR expressing cells (Fig. 3-8D). In contrast to the 
TIF and multiple telomere signal phenotypes, the growth defect of cells 
expressing ApolloΔTRF2 was not as severe as cells expressing the hairpin 
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alone (Fig. 3-9C). This data indicates that Apollo is required specifically at 
telomeres to suppress DNA damage signaling in S-phase.  
 














Figure 3-8. TIFs are not rescued by expression of ApolloΔTRF2.  
(A) IF showing colocalization of 53BP1 (green) with telomeric sites marked by TRF1 
(red) with DAPI staining to represent the nucleus (blue) in BJ-hTERT cells expressing an 
allele of Apollo that can not bind to TRF2 (indicated on the left). (B) Quantification of 
TIFs shown in (A). (C) Quantification of the number of TIFs per cell. Bar graph 
representing data derived from images as shown in (A). The percentage of foci co-
localizing with TRF1 was determined in nuclei with ≥5 TIFs. (D) Quantitative analysis of 
the fraction of DNA damage foci that co-localize with telomeres. For each TIF positive 
nucleus the percentage of foci co-localizing with TRF1 was determined (E) Western Blot 
showing the relative expression of Apollo and ApolloDTRF2 with and without 




Figure 3-9. Multiple telomere signals on a single chromatid are not rescued by 
expression of ApolloΔTRF2. 
(A) Metaphase spreads illustrating the presence of multiple telomere signals at single 
chromatid ends. Metaphase spreads were obtained from BJ-hTERT cells treated with the 
indicated shRNAs or mutants and processed for telomeric FISH (FITC, green). DNA was 
stained with DAPI (false colored in red). Arrowheads highlight chromatids with multiple 
telomere signals. (B) Quantification of multiple telomere signals shown in (A). (C) 
Growth curve of cell lines expressing Apollo and ApolloΔTRF2 . IMR90 cells were 
infected with the indicated shRNA retroviruses and subjected to puromycin selection for 
three days. Subsequently, cells numbers were measured at the indicated time points with 
day 0 representing the first day after puromycin selection. 
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Effect of replication inhibition on telomeres and Apollo 
  Because of the presence of S-phase specific telomere damage upon 
Apollo inhibition, we investigated whether the multiple telomere signals 
observed by FISH were also replication related, perhaps representing 
blocked replication forks. Cells were treated with Aphidicolin [0.3 µM] at a 
concentration that has been reported to induce expression of fragile sites 159, 
and monitored telomere status by FISH for the presence of multiple 
telomeric signals in metaphase chromosomes. Aphidicolin acts by 
competing with each of the four dNTPs for binding to a DNA polymerase α-
DNA binary complex 160 and at fragile sites, aphidicolin induces gaps and 
breaks that lead to sister chromatid exchanges, translocations, and deletions 
161 162. Aphidicolin treatment resulted in a two-fold increase in the frequency 
of multiple telomere signals per chromosome end in Apollo knockdown 
cells as compared with Luciferase controls (Fig. 3-10A-B). Metaphase 
spreads from Apollo deficient cells treated with Aphidicolin were analyzed 
using Chromosome Orientation-FISH (CO-FISH) to examine the frequency 
of telomere sister chromatid exchanges (T-SCEs) 163) (Fig. 3-11A). 
Although there was not a significant difference in T-SCEs in Apollo 
knockdown cells compared with Luciferase controls, all cells that were 
treated with Aphidicolin showed elevated levels of T-SCEs (9-10%) (Fig. 3-
11B-C). Thus, Aphidicolin has two striking effects on telomeres. First, it 
increases the frequency of aberrant telomere structures in cells with 
diminished Apollo levels. Second, Aphidicolin induces a strong increase in 








Figure 3-10. Aphidicolin treatment of cells expressing Apollo shRNAs increase the 
occurrence of multiple telomere signals on single chromatids.  
(A) Metaphase spreads illustrating presence of multiple telomere signals at single 
chromatid ends. Metaphase spreads were obtained from p53-/- MEFs treated with the 
indicated shRNAs +/- Aphidicolin for 20 h [0.3 µM] and processed for telomeric FISH 
(FITC, green). DNA was stained with DAPI (false colored in red). Arrowheads highlight 
chromatids with multiple telomere signals. Metaphases were harvested at day 5 post-
selection. (B) Quantification of single-chromatid multiple telomere signals in p53 -/- 













Figure 3-11. Treatment with Aphidicolin increases the occurrence of T-SCEs. 
(A) Schematic representation of T-SCE detection using CO-FISH {Bailey et al., 1996, 
Mutagenesis, 11, 139-44}. (B) Metaphase spreads illustrating presence of T-SCEs in cells 
treated with Aphidicolin. Metaphase spreads were obtained from BJ-hTERT cells treated 
with the indicated shRNAs for 5 days and then treated with +/- [0.3 µM] Aphidicolin for 
20 h and processed for CO-FISH. DNA was stained with DAPI. Arrowheads highlight 





Apollo loss from the telomere does not induce T-loop HR 
 As described in Chapter 1, the overexpression of an allele of TRF2 
that lacks its N-terminal basic domain (TRF2ΔB) leads to homologous 
recombination at the telomere with two products: short telomeres and 
telomere circles detected by 2-D gel electrophoresis 86. We speculated that 
the multiple telomere signals on a single chromatid might represent the 
products of t-loop HR with the recombined t-loop still attached by telomeric 
cohesion 128 164. We therefore assayed for the presence of telomere circles in 
Apollo knockdown cells. 
 To assay for telomere circles, we employed a technique based on 
rolling circle amplification (RCA). In the Telomere Circle Amplification 
(TCA) technique, products of t-loop HR are annealed to telomere specific 
primers that serve as a template for RCA using the highly processive DNA 
polymerase Φ29 (Fig. 3-12A) 88. The extension products are separated from 
bulk DNA by alkaline electrophoresis and detected by southern 
hybridization. The specificity of the reaction was tested by Exonuclease V 
treatment of samples, which hydrolyzes nucleotides from 3' and 5' ends of 
linear double-stranded DNA and single-stranded DNA. Bulk DNA was 
efficiently degraded by Exonuclease V and telomere circles from these 
reactions were resistant.  
 TCA assays on DNA extracted from BJ cells expressing TRF2ΔB 
consistently showed a 20-30 fold increase in t-circles compared to control 
cells, confirming in an independent experimental setting previous findings 
that TRF2ΔB overexpression results in t-loop HR 86 (Fig. 3-12B). In 
contrast, DNA from cells with decreased levels of Apollo or from cells 
expressing ApolloΔTRF2 showed a very mild increase in telomere circles 
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(2-4 fold) in comparison to control samples (Fig. 3-12B). As previously 
described in this section, cells that have been treated with Aphidicolin have 
an increase in the number of multiple telomere signals detected by FISH 
(Fig. 3-10A-B). DNA extracted from these cells was tested for the presence 
of telomere circles. There was no increase in telomere circles detected by 
TCA in Apollo knockdown cells treated with Aphidicolin indicating that the 






Figure 3-12. Telomere Circle Amplification (TCA) analysis of BJ cells expressing 
Apollo shRNA and Apollo mutant alleles.  
(A) Schematic representation of primer elongation by the φ29 polymerase from a circular 
template 88.The lower case cytosines in the primer represent thiophasphate linkages 
between the three terminal nucleotides to prevent primer degradation by φ29 exonuclease 
activity. (B) Detection of t-circles in BJ fibroblasts. TCA reaction was performed +/- φ29 
polymerase on 2 µg of digested genomic DNA annealed with 1 µM (CCCTAA)3ccc 
containing thiophosphate linkages at the 3’ end. Extension products were separated by 
denaturing gel electrophoresis and hybridized to a 800 bp telomeric DNA probe (Sty11). 
Samples were harvested 5 days post-selection. Aphidicolin treated samples were 
incubated with [0.3 µM] Aphidicolin for 20 hours prior to harvesting. Quantification was 
performed using ImageQuant software. T-circle intensities were normalized to the linear 




 Experiments described in this chapter reveal that Apollo is required at 
telomeres to suppress DNA damage signaling during S-phase. Primary cells 
with reduced amounts of Apollo senesced and showed telomere dysfunction 
in S-phase. Additionally, a subset of telomeres in Apollo deficient cells 
showed multiple telomere signals by FISH that increased after treatment 
with Aphidicolin, possibly indicating an aberrant structure at chromosome 
termini. Together, these data indicate that Apollo has a role in processing 
telomeres during or after replication.   
 Telomeres represent 0.01% of the genome. Human cell cultures 
treated with [0.2 µM] Aphidicolin are reported to have 16-17 SCEs per cell, 
with ~80% of these events occuring at fragile sites 165. If random, a T-SCE 
event would occur at one of every 625 telomeres in cells treated with 
Aphidicolin. Strikingly, 8-10% of telomeres have exchanges, providing 
strong evidence that telomeres behave like fragile sites and are likely to be 
difficult templates to replicate. Corroborating this finding, TIFs are also 
prevalent in p53-/- MEFs treated with Aphidicolin (K. Hoke and T. de 
Lange unpublished results).  
 The replication inhibitor Aphidicolin increased the frequency of 
multiple telomere signals in Apollo knockdown cells. These aberrant 
telomere structures have also been noted in MEFs from which TRF1 was 
deleted (A. Sfeir and T. de Lange, unpublished data). Taz1, the fission yeast 
ortholog of mammalian TRF1 and TRF2, is required for the replication of 
telomeres 112. Taz1 is predicted to act by either altering the telomere 
complex to allow for replication fork passage or by recruiting proteins (e.g. 
the RecQ helicase) to unwind G-quartet structures on telomere repeats. 
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TRF1 and TRF2 might act in a similar fashion, where TRF2 recruits the 
Apollo nuclease to telomeres to resolve non-covalent structures that would 
impede the replication fork. Apollo might act also in the context of the 





CHAPTER 4: APOLLO AFFECTS THE AMOUNT OF 
SINGLE STRANDED DNA AT TELOMERES 
  
Nuclease Processing of Telomeres 
The Mre11 complex at telomeres in Saccharomyces cerevisiae 
 Without additional processing after replication, chromosomes are 
predicted to have one blunt end produced by leading strand synthesis and 
one end with a short G-rich overhang created by a gap at the 5' end of the 
newly lagging strand synthesized C-rich strand. Studies in S. cerevisiae 
show that yeast telomeres acquire 3' G-rich overhangs in S phase 166 and that 
these overhangs are detectable on both leading and lagging strand ends of 
linear plasmid DNA recovered from yeast 167, indicating that both ends of a 
newly replicated chromosome are likely to be processed by a nuclease. 3' G-
rich telomere overhangs are present in cells lacking telomerase 168 and the 
passage of the replication fork through the telomere sequence has been 
shown to be required for their generation 169. Studies in a variety of 
organisms show that a G-rich tail is a universal feature of all telomeres. 
 Telomeres in budding yeast deleted for any member of the MRX 
(Mre11-RAD50-Xrs2) complex are short but stable 170. Cells with an MRX 
deletion combined with Mec1 (ATR) acquire an est (ever shorter telomere), 
characterized by progressive telomere shortening and eventual senescence. 
When combined with Tel1 (ATM), deficiency for MRX does not lead to an 
est phenotype, consistent with the view that Tel1 and MRX function in the 
same pathway 171. The MRX complex was also found in the same epistasis 
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group as genes encoding telomerase components and was predicted to 
prepare ends for elongation by telomerase 172. Mutation or deletion of MRX 
components leads to defects in homologous recombination and non-
homologous end joining 173 174 175 170. Mre11 has single stranded 
endonuclease activity and a 3'-5' exonuclease activity in vitro 176 177, while 
the MRX complex in vivo is implicated in 5'-3' resection of DSBs in budding 
yeast 178 176. This dilemma could be explained if Mre11 recruits a different 
nuclease to sites of damage or uses its endonuclease activity in conjunction 
with a DNA helicase. In this regard, the human ortholog of Xrs2 (Nbs1) has 
been shown to display some low DNA helicase activity in vitro 179. 
 There are conflicting data regarding the role of the S. cerevisiae MRX 
complex in telomere resectioning after replication. In one report, rad50Δ, 
mre11Δ, and xrs2Δ strains show diminished loading of Cdc13 and reduced 
telomere addition at an HO cut 180. This suggests that MRX is involved in 
generating the 3' G-rich overhang. In another report, wild type levels of 
Cdc13 were detected at telomeres by ChIP in rad50Δ, mre11Δ, and xrs2Δ 
strains 181. Furthermore, senescence was suppressed in mec1Δ mrxΔ strains, 
and telomere lengthening occurs efficiently in mec1 mrxΔ and mrxΔ strains 
by targeting Cdc13-telomerase fusion proteins to telomeres, suggesting that 
G-tails are present in the absence of the MRX complex 181. A third study 
found that short G-tails (10-15 nt) are present throughout the cell cycle and 
that these overhangs are shorter in mre11Δ, but not completely abolished 182. 
 The MRX complex has a further role in telomere maintenance in 
telomerase-deficient strains. Most yeast cells senesce in telomerase-deficient 
strains after ~80-100 generations, yet some cells survive and maintain their 
telomeres in a recombination-dependent manner 31. The majority of such 
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survivors use a pathway (referred to as Type I) that leads to multiple tandem 
copies of the subtelomeric Y' element and short terminal tracts of C1-
3A/TG1-3. Type I survivors are dependent on Rad51p as well as Rad52p. 
Telomeres in the Type II survivor pathway show progressive shortening 
followed by a single, rapid elongation event that is dependent on Rad52p 
and Rad50p but not Rad51p 32 33. The maintenance of telomeres in the Type 
II survivor pathway has been proposed to involve rolling circle replication of 
extra chromosomal telomeric circles 32.  
Mre11 complex and XPF/ERCC1 nucleases at human and mouse telomeres  
 Human and mouse telomeres possess long G-rich overhangs that are 
45-275 nucleotides in length 183 184 185. The presence of overhangs is not 
dependent on telomerase 186. Recent studies have shown that overhangs 
generated in human primary cells by leading and lagging strand synthesis are 
asymmetrical, with longer overhangs at lagging strand ends 187. This study 
suggests the possibility that leading and lagging strand telomeres are 
processed by different mechanisms. This asymmetry is not observed in 
telomerase-positive cells, indicating that either telomerase affects telomere 
processing differently on leading and lagging strand overhangs or that 
telomerase extends overhangs differently. 
 Mutations in the Nbs1 and Mre11 components of the human MRN 
complex cause Nijmegen Break Syndrome (NBS) and Ataxia-telangiectasia-
like disorder (ATLD), respectively 188 189 190. Patients afflicted with these 
disorders show radiation sensitivity, chromosomal instability, predisposition 
to cancer, and neurological abnormalities. Additionally, peripheral 
lymphocytes from NBS patients have shortened telomeres and Nbs1 has 
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been shown to promote telomerase-mediated telomere elongation 93. The 
MRN complex is present at human telomeres where it binds to TRF2 16.  
 A role for the MRN complex in the generation of the 3' overhang in 
human cells has been suggested by studies that show shorter overhangs in 
telomerase-positive cells treated with siRNA targeting Mre11, Rad50, and 
Nbs1 191. The 3' overhang was unaffected after depletion of the Mre11 
complex in telomerase-deficient cells, suggesting that MRN might be 
involved in the recruitment of telomerase or that telomerase must be present 
for MRN activity at telomeres. The 5' terminal nucleotide is unaffected in 
Mre11-deficient cells  (see below for 5' end details). These data suggest that 
multiple nucleases are likely involved in post-replicative processing of 
telomeres and generation of the 3' overhang 191. 
 The Nucleotide Excision Repair (NER) heterodimer XPF/ERCC1 is 
another nuclease recruited to telomeres by TRF2. ERCC1 in mouse cells 
prevents the generation of Telomere Double Minutes (TDMs), perhaps by 
inhibiting telomeres from strand invading interstitial telomere related 
sequences 78. XPF/ERCC1 has also been implicated in clipping the 3' 
overhang from deprotected telomeres, creating a substrate for NHEJ 78.  
The role of Pot1 in regulating nucleases at mammalian telomeres 
 Knockdown of human Pot1 results in a partial loss of the telomeric 
ssDNA signal (~30-40%) in telomerase-positive and negative cells 149. This 
diminished G-strand signal might occur due to incomplete processing of the 
telomere after replication, possibly by insufficient end-resection by a C-
strand specific nuclease. Alternatively, Pot1 deficient cells may form 




 Whereas human telomeres have a single Pot1 gene, there are two 
mouse Pot1 genes, Pot1a and Pot1b 150. Pot1a is an essential gene because it 
is required to suppress the DNA damage signal at mouse telomeres. Pot1b 
regulates the amount of single stranded DNA at mouse telomeres and is not 
essential 150. Removal of Pot1b in conditional MEFs leads to a 2-3 fold 
increase in the amount of single stranded DNA at telomere termini. The 
enhanced shortening rate of Pot1b-/- MEFs is consistent with the 5' 
degradation model for telomere shortening proposed by Makarov et al. 183 
indicating that Pot1b actively inhibits a nuclease from improper resectioning 
after telomere replication (Hockemeyer et al, unpublished data). The 5'-3' 
exonuclease Exo I was tested genetically to determine whether it was 
responsible for the excessive 5' resection observed after removal of Pot1b. 
Exo I does not play a role in 3' overhang generation in mouse cells, or is 
redundant with other nucleases, as there was no change in the rate or amount 
of overhang increase after Pot1b deletion in Exo I null MEFs (Hockemeyer 
et al, unpublished data).   
Loss of human Pot1 leads to randomization of the 5' end sequence 
 Telomere ligation experiments by Sfeir et al. have determined that the 
5' end of human chromosomes is extremely specific, ending more than 80% 
of the time with the sequence ATC-5', whereas there is no preference for a 
specific terminal nucleotide in the G-rich strand 8. The telomere ligation 
assay used in these studies is a modified version of STELA (Single 
Telomere Ligation Assay), where a limiting amount of genomic DNA is 
ligated to a set of primers specific for each of the six permutations of the 
telomeric sequence AATCCC. These “telorettes” contain a cassette 5' to 
their telomere sequences that can be PCR amplified. A PCR primer specific 
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to the subtelomeric region of the X-chromosome and the telorette are used to 
amplify individual telomeres (Fig. 4-2A).  
 Pot1 is responsible for determining the 5' nucleotide of chromosome 
ends as demonstrated by the randomization of the 5' end into all six 
permutations of the telomere repeat 3'-AATCCC-5' in Pot1 knockdown cells 
149. Pot1 may act by recruiting an endonuclease or a 5'-3' exonuclease to the 
telomere after replication and direct it to cleave specifically at the site 3'-
AATC*CC-5'. Alternatively, Pot1 may specifically recognize ATC-5' and 
protect it from nucleolytic attack.  
Apollo is predicted to have nuclease activity 
 In the experiments described in this chapter, the assumption is made 
that Apollo acts as a nuclease at telomeres. This assumption is made on the 
basis that Apollo is a member of the β-CASP (metallo- β-lactamase-
associated CPSF Artemis SNM1/PSO2) family of proteins, part of the 
metallo−β-lactamase superfamily130. Other members of this family include 
Artemis, SNM1A (sensitivity to nitrogen mustard 1A), and CPSF (cleavage 
and polyadenylation specificity factor), whose activities are involved in 
DNA repair and RNA processing. The histidine and glutamic acid residues 
required for enzymatic activity and the coordination of Zn++ ions in the 
metallo-β-lactamase domain of Artemis are conserved in Apollo 142. Artemis 
possesses intrinsic 5'-3' exonuclease activity and acquires endonucleolytic 
activity on 5' and 3' overhangs when in complex with DNA-PKcs 134. 
Mutations in human Artemis cause RS-SCID (Radio sensitive severe 
combined immune deficiency), indicating that Artemis is required for V(D)J 
recombination and double strand break repair 133. PSO2/SNM1 (Psoralen 
mutant 2/sensitivity to nitrogen mustard 1), the budding yeast ortholog of the 
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SNM1A/Apollo/Artemis family, has a role in interstrand crosslink repair 192 
193 194. Conservation of this function is evident in Apollo and SNM1A. HeLa 
cells with reduced levels of Apollo 139 and DT40 cells deleted for Apollo 195 
show diminished survival when treated with the interstrand crosslink (ICL) 
inducing agents MMC and cisplatin. SNM1A-/- embryonic stem cells are 
highly sensitive to treatment with MMC but not other ICL inducing agents 
138. Finally, in vitro work by the Gilson lab has suggested that Apollo has 5'-
3' exonuclease activity 148.  
 As described above and in Chapter 1, there are many events in 
telomere metabolism where a nuclease is required, including 5' end 
processing of chromosome termini and NHEJ of dysfunctional telomeres. 
We probe these aspects of telomere regulation in the following experiments 
and ask where the putative Apollo nuclease acts.  
Results  
Apollo negatively regulates the amount of ssDNA at telomeres 
 To assess the possible role of Apollo in creating the correct telomere 
terminus structure, we examined the status of the 3' overhang in BJ primary 
fibroblasts treated with an Apollo shRNA-UTR4 that was previously shown 
to be effective (Fig. 3-1). After growth for 5 days (~4 PD) with lowered 
Apollo levels, there was no detectable change in the amount of telomeric 
ssDNA compared with control cells (Fig. 4-1A-B). In contrast, BJ cells that 
overexpress wild type Apollo or ApolloΔN have a mild reduction in the 
amount of ssDNA (75-90% of control signal). This difference was 
statistically significant (p<0.01) and observed in three independent 
experiments. Overexpression of ApolloΔTRF2 consistently increased the 
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amount of ssDNA at telomeres (~125% of control signal, p<0.001) (Fig. 4-
1A-B). This result would suggest that Apollo is a negative regulator of 
overhang generation and that ApolloΔTRF2 acts to interfere with this 
function. Such a dominant effect for ApolloΔTRF2 has also been 
documented in Chapter 3.  
 
















Figure 4-1. Overexpression of Apollo alleles affect the status of the 3' overhang.  
(A) Telomeric DNA analysis. (Left) In-gel assay detecting 3' overhang in BJ fibroblasts 
expressing Vector control, Apollo shRNA UTR, pLPC-FLAGHA2-Apollo, pLPC-
FLAGHA2-ApolloΔTRF2, and pLPC-FLAGHA2-ΔNApollo. In-gel hybridization to a 
(CCCTAA)4 probe to detect ssTTAGGG repeats (native). (Right) The DNA was 
denatured in situ and rehybridized to the same probe to detect the total TTAGGG signal 
(denatured). Overhang signals were quantified with ImageQuant software and normalized 
to the total TTAGGG signal in the same lane. The numbers below the gel represent the 
percentage of normalized overhang signals compared with the normalized overhang 
signal for vector control treated cells. Numbers on the left indicate the size of telomere 
fragments in Kb (B) Quantification of telomeric overhang 5 days post infection in three 
independent experiments compared with vector control. Student's t test was performed to 
generate p values (C) Immunobloting for expression of Apollo alleles in BJ fibroblasts. 










Apollo does not define the 5' end sequence of chromosomes 
 To test the possibility that Apollo is involved in determining the 5' 
terminal sequence, we collaborated with the Wright and Shay Lab (UT 
Southwestern) to execute STELA assays in order to monitor the ends of 
chromosomes in cells that either overexpress Apollo or cells that were 
knocked down for Apollo. STELA indicated that the 5' end of chromosomes 
from BJ cells with altered Apollo levels harvested five days post selection 
did not show any evidence of randomization (Fig. 4-2B). The experiment 
was repeated in BJ-SV40 cells, which tolerate Apollo knockdown without 
senescing, allowing assays at later time points. Fourteen days after selection 
there was no randomization of the 5' end under these conditions in Apollo 
knockdown cells, whereas Pot1 knockdown resulted in the expected loss of 




Fig. 4-2. No change in the 5' end sequence of human chromosomes in Apollo 
deficient cells.  
(A) Schematic of the ends of human chromosomes and the 5' telorette assay. The six 
telorettes and the 5' ends to which they can ligate are shown. PCR primers used for 
amplification are shown schematically. (B) Products of the 5' telorette assay in BJ 
fibroblasts expressing pLPC-FLAGHA2-Apollo, control shRNA or Apollo shRNAs H2 
and H6. Cells were harvested five days post selection.  Each telorette was used for 2-3 
independent assays and the products were run in separate lanes. (C) Products of the 5' 
telorette assay in BJ-SV40 cells expressing Luciferase control shRNA,  positive control 
Pot1 shRNA and Apollo shRNA UTR. Cells were harvested 14 days after selection. Each 
telorette was used for three independent assays and the products were run in separate 




 To further test the possibility that Apollo affects the 5' end sequence, 
we looked in a setting where Pot1 was knocked down which leads to loss of 
5’ end specificity. Cells were treated with Pot1 shRNA for a time period 
sufficient to induce randomization of the 5' end and subsequently treated 
with Apollo shRNA for two weeks to determine if the randomization would 
be reversed. Knocking down Apollo in Pot1 deficient cells did not rescue 
randomization (Fig. 4-3A). Finally, we asked whether randomization of the 
5' end upon Pot1 loss could occur in a setting with reduced Apollo. Apollo 
levels were decreased for ten days prior to introduction of Pot1 shRNA. 
Randomization of the 5' end in cells expressing Apollo, ApolloΔTRF2, and 
the Apollo hairpin shUTR was not impeded (Fig. 4-3B). Apollo does not 
appear to have a role in determining the 5' end in the experimental settings 




Figure 4-3. Apollo deficiency does not rescue randomization of the 5' end in Pot1 
deficient cells.  
(A) Products of the 5' telorette assay in BJ-SV40 cells expressing Luciferase control 
shRNA, Apollo shRNA UTR , Pot1 shRNA, and Pot1 shRNA/Apollo shRNA UTR. 
Luciferase and Apollo shRNA UTR expressing cells were harvested 14 days after 
selection, Pot1 shRNA expressing cells were harvested 28 days after selection. Each 
telorette was used for two independent assays and the products were run in separate 
lanes. The telorette corresponding to the 5' end detected is shown above the lanes. (B) 
Products of the 5' telorette assay in BJ-SV40 cells expressing Luciferase control shRNA, 
, Pot1 shRNA, Pot1 shRNA/Apollo shRNA UTR, Pot1 shRNA/Apollo and Pot1 
shRNA/ApolloΔTRF2. Cells were harvested at 10 days (Luciferase and Pot1 shRNA) and 
20 days (Pot1 shRNA/Apollo shRNA UTR, Pot1 shRNA/Apollo, and Pot1 
shRNA/ApolloΔTRF2) post selection. Each telorette was used for two independent 
assays and the products were run in separate lanes. The telorette corresponding to the 5' 




Diminished 5' end resection upon Apollo inhibition in Pot1b null cells 
 To determine whether Apollo is the nuclease that causes excessive 5' 
resection after removal of mouse Pot1b, mApollo was knocked down in 
Pot1b Stop/Flox conditional MEFs (Fig. 4-4D). The effect of Apollo 
shRNAs was consistent with findings at human telomeres, there is no change 
in the 3' overhang status in MEFs with reduced Apollo levels (Fig. 4-4A-B). 
Cre recombinase was added 5 days after selection for Apollo knockdown to 
take away the remaining allele of Pot1b and cells were harvested 3-7 days 
later. As expected, removing Pot1b resulting in a 2.6-3.2 fold increase in the 
amount of ssDNA at telomeres. In contrast, in Apollo knockdown cells there 
was only a 1.4-2 fold increase in ssDNA after removing Pot1b (also 
expressed as 70% of the increase in telomere ssDNA observed in Luciferase 
control cells deleted for Pot1b) (Fig. 4-4A-B). In the reverse setting, where 
Apollo is downregulated in cells already deleted for Pot1b, there is a 
consistent, but very mild reduction in the ss-DNA signal generated from 
Pot1b loss (88-90% of Pot1b+Luciferase levels) (Fig. 4-4E-F). These results 
suggest that, at least in one setting, Pot1b acts to reduce the access of Apollo 


























Figure 4-4. mApollo participates in the degradation of the 5' end after removal of 
Pot1b. 
(A) Telomeric DNA analysis. (Left) In-gel assay detecting 3' overhang of Pot1bStop/Flox 
SV40 MEFs expressing control Luciferase or Apollo shRNA ORF4. Cells were harvested 
six days post-infection with cre and processed with in-gel hybridization to a (CCCTAA)4 
probe to detect ssTTAGGG repeats (native). (Right) The DNA was denatured in situ and 
rehybridized to the same probe to detect the total TTAGGG signal (denatured). Overhang 
signals were quantified with ImageQuant software and normalized to the total TTAGGG 
signal in the same lane. The numbers below the gel represent the percentage of 
normalized overhang signals compared with the normalized overhang signal for the same 
cells not treated with cre and the relative overhang increase of shRNA treated cells 
compared to Luciferase treated cells six days after cre introduction (bottom in 
parenthesis). (B) Quantification of telomeric overhangs in three independent experiments 
compared with +/- cre and Luciferase control. Student’s t test was used to generate p 
value. (C) Immunobloting for mPot1b in Pot1b Stop/Flox MEFs +/- cre. (D) RT-PCR 
analysis with primers for mApollo and GAPDH loading control. (E) Telomeric DNA 
analysis as in (A) in Pot1b Stop/Flox MEFS infected with pWZL-cre and selected for 
Pot1b deletion in hygromycin-containing medium for 12 days and subsequently infected 
with control shRNA and Apollo shRNAs ORF1, ORF2 and ORF4. (F) Quantification of 












Apollo does not affect overhang loss after TRF2 deletion 
 We tested whether the loss of Apollo had any influence on the rate of 
telomeric ssDNA loss after TRF2 deletion. mApollo was knocked down in 
TRF2 Flox/null conditional MEFs. Cells were harvested at 72 and 96 hours 
after the introduction of Cre recombinase. The overhang signal was 
monitored by native in-gel hybridization and normalized to the total 
telomeric DNA in the same lane. There was no change in the rate of 
overhang loss between control and Apollo knockdown cell lines (Fig. 4-5A). 
Additionally, there was no obvious difference in the extent of telomere 
fusions as detected by the appearance of larger telomeric DNA fragments at 
the different time points (Fig. 4-5A). These results suggest that Apollo does 




Figure 4-5. Apollo deficiency does not affect overhang loss in cells deleted for TRF2.  
(A) Telomeric DNA analysis. (Left) In-gel assay detecting 3' overhang of TRF2F/-p53-/- 
MEFs expressing control Luciferase or Apollo shRNA ORF2. Cells were harvested 72 h 
and 96 h post-infection with cre and processed in-gel hybridization to a (CCCTAA)4 
probe to detect ssTTAGGG repeats (native). (Right) The DNA was denatured in situ and 
rehybridized to the same probe to detect the total TTAGGG signal (denatured). Overhang 
signals were quantified with ImageQuant software and normalized to the total TTAGGG 
signal in the same lane. The numbers below the gel represent the percentage of 
normalized overhang signals compared with the normalized overhang signal for the same 
cells not treated with cre. (B) Immunobloting for mTRF2 in MEFs at the indicated time 
points after cre introduction. (C) RT-PCR analysis with primers for mApollo and 







 The experiments discussed in this chapter addressed the possibility 
that Apollo might contribute to the generation or removal of single stranded 
telomeric DNA. No evidence emerged to support a role for Apollo in 
defining the 5' sequence of chromosome ends or in the same pathway as 
XPF/ERCC1 in removing the 3' overhang at deprotected telomeres. As the 
experiments employed a shRNA knockdown and overexpression strategies, 
such negative results are not interpretable. In contrast, Apollo affects the 
amount of ssDNA at telomeres in settings where different alleles of Apollo 
are overexpressed and after removal of Pot1b in mouse cells. The 
implications of these results are discussed below.  
 The terminal structure of chromosomes implies that there is extensive 
post-replicative processing of telomeres. We found that Apollo negatively 
regulates the amount of ssDNA at human telomeres. Apollo could function 
by inhibiting resection of the 5' end or by preventing extension of the 3' end 
of the overhang. Expression of ApolloΔTRF2, a point mutant that cannot be 
recruited to telomeres, results in an increase in overhang signal, interfering 
with this function possibly by titrating factors required for the negative 
regulation of ssDNA away from the telomere. In human and mouse cells, 
Apollo deficiency alone does not change the amount of ssDNA at telomeres. 
 In Pot1b null MEFs less of the 5' end is resected in the absence of 
Apollo, suggesting that Pot1b functions in part by inhibiting the activity of 
Apollo at the 5' end. In the reverse setting, Apollo knockdown only mildly 
affects the amount of ssDNA at telomeres. The 12 day period between Pot1b 
deletion and mApollo knockdown might provide a sufficient window where 
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other nucleases might act instead of Apollo. Only through genetic 
experiments will we be able to answer definitively whether Apollo is the 
principal nuclease involved in the 5' resection of mouse telomeres.  
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CHAPTER 5: THE APOLLO COMPLEX 
Introduction 
 
 To gain insight into the pathway(s) Apollo functions in, we sought to 
identify interacting proteins. We found DBC-1, the translesion bypass 
polymerase polη, and Rad51 in the Apollo complex. The biological 
pathways relevant to these factors are discussed in this introduction.  
DBC-1 
The gene encoding DBC-1 was originally identified during a search for 
candidate tumor suppressor genes in a frequently deleted region in breast 
cancers on human chromosome 8p21 196. However, after a more refined 
deletion analysis it appeared that DBC-2 is more likely to be the candidate 
tumor suppressor gene. In support of this conclusion, the authors found that 
in contrast to DBC-2, DBC-1 expression was not diminished in any type of 
cancer tissue tested. Furthermore, the Oncomine database 
(www.oncomine.org) revealed that DBC-1 is actually upregulated in breast 
carcinoma versus normal breast tissue and in breast ductal carcinoma versus 
other tissues 197. Little is known about the molecular function of DBC-1. 
Full-length-nuclear DBC-1 undergoes caspase-dependent processing during 
TNF-α-mediated death signaling, producing two N-terminally truncated 
versions that localize to the cytoplasm 198. However, its localization is 
primarily nuclear in healthy cells 198. Recently, DBC-1 was found to bind 
directly to the steroid hormone estrogen receptor-α (ER-α) in a ligand 
independent manner 197. Estrogen has been shown to induce and promote 
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breast cancer in animal models and ER-α is a target for endocrine therapy 
with antiestrogens such as tamoxifen and Icl in breast cancer patients. In the 
absence of a ligand, siRNA against DBC-1 reduced the level of ER-α in the 
cell, implicating DBC-1 in the stabilization of unliganded ER-α.  
 DBC-1 contains a Leucine Zipper motif, an EF hand domain, and a C-
terminal coiled coil domain (Fig. 5-2A). Interestingly, a DBC-1 
phosphorylated peptide containing T454 was recovered in a screen of HeLa 
nuclear proteins 199. This site was independently predicted to be a 
phosphorylation target of a PIKK kinase 200. 
Cajal Bodies 
 As shown in this chapter DBC-1 localizes to Cajal bodies. Cajal 
bodies (CBs) are dynamic subnuclear domains implicated in the biogenesis 
and maturation of several classes of small ribonucleoproteins (RNPs).  The 
human telomerase RNA subunit (hTR) has been recently found to localize to 
Cajal bodies 201 202. hTR contains a Cajal body box (CAB) motif found in 
small Cajal body-specific RNAs (scaRNAs). Mutation of the CAB motif 
abolishes the localization of hTR to CBs 201. This permitted experiments to 
ask what role Cajal bodies have in telomerase function. Studies by Cristofari 
et al. 203 found that there was no change in the in vitro telomerase activity of 
CAB-mutated hTR compared with wild type hTR using a primer extension 
assay. However, HT1080 and HeLa cells co-overexpressing hTERT and 
mutant hTR had impaired telomere elongation. Additionally, hTERT was 
detectable by ChIP at telomeres in cells co-overexpressing hTERT and wild 
type but not mutant hTR. These data suggest that while Cajal bodies may be 
dispensable for telomerase biogenesis, they contribute to telomerase 
recruitment at telomeres. This might occur in two nonexclusive ways. A 
 
96 
maturation step essential for the productive association of telomerase RNP 
with telomeres might occur in Cajal bodies or the telomerase RNP might 
associate with a protein in Cajal bodies that can recruit telomerase to 
telomeres.  
Rad51 and Translesion Bypass Polymerase Polη  
 Rad51 is part of the RecA/RAD51 family of recombinases that have 
key functions in homologous recombination (HR). Members of this family 
have the unique ability to search for homologous sequences and to catalyze 
the exchange of DNA strands between two molecules. HR is used by mitotic 
cells to repair collapsed replication forks and double strand breaks and in 
meiosis, HR is required for the exchange of genetic information. Double 
strand break repair by HR is generally error free and takes place in S/G2 
when a sister chromatid is present. The first step involves 5'-3' resection of 
broken ends (possibly by the MRN complex), and stabilization of ssDNA by 
RPA binding.  Subsequent displacement of RPA by Rad51 filament 
formation occurs on ssDNA. Rad52 and BRCA2 204 facilitate this step. The 
Rad51 filament then performs a search for homologous sequences to use as a 
template for repair. A D loop is created by the subsequent invasion of the 
Rad51 filament into double stranded DNA. This reaction is promoted by 
Rad54. Next, a DNA polymerase synthesizes DNA using the undamaged 
sister chromatid as a template. The resulting double Holliday Junction is 
resolved to finalize the HR reaction. 
 Polη is part of the Y-family of lesion bypass polymerases that 
includes Polι, Polκ, and Rev1. These specialized polymerases have more 
open active sites than canonical DNA polymerases 205. This feature allows 
this family of polymerases to negotiate distorted DNA templates. Polη is 
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able to replicate across DNA lesions such as cisplatin-induced inter-strand 
crosslinks and UV-induced cyclobutane pyrimidine dimers (CPDs) 206 207 208 
209 210. Polη is thought to be recruited to the replication machinery through 
monoubiquitination of PCNA that results in replication across CPDs 211. 
Polη has low intrinsic processivity and is predicted to switch out shortly 
after replicating opposite a lesion. Deficiency in polη is the cause of XP-V 
(Xeroderma Pigmentosum Variant) 206 207, an inherited disorder whose 
patients exhibit a dramatic increase of sunlight induced cancers. Cells 
derived from XP-V patients are deficient in their ability to replicate across 
UV-damaged DNA 206. 
 More recently, a role in the DNA synthesis step of homologous 
recombination has been proposed for polη. A DNA polymerase is expected 
to synthesize DNA in the dynamic D loop created by strand invasion during 
homologous recombination. It was not known whether conventional DNA 
polymerases performed this function or if specialized polymerases were 
involved. McIlwraith et al. 212 were able to purify an active fraction from 
HeLa nuclei that could extend D loops in vitro. Immunoblotting of this 
fraction revealed the presence of polη and polδ but not other DNA 
polymerases. Further tests showed that purified polη, but not polδ, was able 
to extend D loops in vitro. D loop extension was severely impaired when 
tested using polη deficient XP-V extracts compared with HeLa extracts. 
Electromobility shift assays (EMSA) demonstrated that polη can bind D 
loops better than forked DNA and ss- and ds-DNA substrates. Interestingly, 
a direct interaction between polη and Rad51 was observed in HeLa cells 
after exposure to UV irradiation 212. Furthermore, Rad51 stimulated polη 
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extension of D loops at low concentrations of polη suggesting a mechanism 
for the recruitment or stabilization of polη at the stand invaded 3' end.  
Results 
Most soluble Apollo is complexed at 1:1 stoichiometry with TRF2/Rap1  
 We isolated the Apollo protein complex using the high salt, nuclear 
extraction technique described in Chapter 2. The isolated complex was 
analyzed by Coomassie staining after gel-electrophoresis. Individual bands 
were excised, digested with trypsin, and analyzed by MS/MS. Three bands 
of equal intensity appeared between the 75 and 50 kDa MW makers that 
corresponded with tagged Apollo, TRF2, and Rap1 (Fig. 5-1A), indicating 
that most of Apollo in the nuclear extract of these cells is associated with 
TRF2/Rap1. The relative abundance of other shelterin components was 
analyzed by western blot. Pot1 and Tin2 were present in relatively high 
amounts in both N-terminally tagged and C-terminally tagged Apollo 
isolates (Fig. 5-1B). In contrast, TRF1 was underrepresented in this Apollo 




Figure 5-1: The Apollo Complex.  
(A) Coomassie stained gel of the Apollo complex after tandem purification using FLAG 
and HA epitopes. Vector control cell line subjected to the same nuclei isolation and 
purification protocol at left. Proteins identified by mass spectrometry are identified in red 
and proteins identified by immunoblotting are in blue. (B) Immunoblotting for the 
presence of shelterin components in the isolated Apollo complex. TRF2 (647), Tin2 
(864), Pot1 (979), TRF1 (371). Both full length Pot1 and an alternatively spliced form of 
Pot1 lacking its N-terminal OB-fold (Pot1-55) are present in the Apollo complex. Input 
(IN), Vector (V), NFHA2-Apollo (N), Apollo-FHA2C (C). Input is 2.5% of IP.  
 
Deleted in Breasted Cancer-1 (DBC-1) directly interacts with Apollo 
 Mass spectrometry identified a protein in the Apollo complex 
migrating at 130 kDa as DBC-1 (Deleted in Breast Cancer-1) (Fig. 5-1A). 
Eighteen different peptides from DBC-1 were recovered in MS/MS analysis 
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(Fig. 5-2C). To verify the presence of DBC-1 in the complex, immunoblots 
were performed on Apollo complexes isolated from HeLa S3 cells 
expressing N- and C-terminally tagged Apollo. Immunoblotting showed an 
obvious enrichment for DBC-1 in the Apollo complexes compared to the 
control (Fig. 5-2B). Roughly 2% of total DBC-1 was recovered in 
association with the Apollo complexes. To determine whether DBC-1 
interacts directly with Apollo, co-IP experiments were performed on 293T 
cells transiently transfected with DBC-1, Apollo, and shelterin factors. 
These experiments demonstrate that DBC-1 directly interacts with Apollo 
but not with any of the shelterin components (Fig. 5-2D). Although Apollo 
binds DBC-1 directly, it is not required for DBC-1 protein stability, as DBC-
1 protein levels were unchanged in extracts made from Apollo knockdown 




Figure 5-2: DBC-1 interacts with Apollo.  
(A) Schematic of DBC-1 indicating domain structure and PIKK phosphorylation site. (B) 
Immunoblot confirming the presence of DBC-1 in the Apollo complex after tandem 
purification using Flag and HA epitopes, α-DBC-1 (Bethyl Labs). (C) Peptides recovered 
from Apollo complex identifying DBC-1. (D) Co-immunoprecipitation experiments 
indicating a direct interaction of DBC-1 with Apollo and not with any shelterin 
component. Flag-DBC-1 was co-transfected with Myc-shelterin in 293T cells (tags 
reversed for TPP1/DBC-1 co-IP). Myc-IPs were probed for the the presence of DBC-1 
(or TPP1 in DBC-1 IP) by immunoblot with Flag antibody. (E) Immunoblot analysis of 




DBC-1 localizes to Cajal Bodies 
 We performed IF on BJ-hTERT cells expressing tagged DBC-1 to 
determine its nuclear localization. Myc-DBC-1 localizes to 7-15 nuclear 
foci, some of which colocalize with telomeres (marked with TRF1) (Fig. 5-
3A). This pattern is reminiscent of Cajal bodies 213 214. To test for the 
presence of DBC-1 in Cajal Bodies, co-immunoflouresence was performed 
with Coilin, a widely used molecular marker for Cajal bodies 215. DBC-1 
clearly and almost exclusively co-localizes with Coilin (Fig. 5-3B). We 
conclude that DBC-1 is a component of Cajal bodies. Considering that 
Apollo and DBC-1 have only partially overlapping subnuclear localizations, 

































Figure 5-3: DBC-1 localizes to Cajal bodies.  
(A) Immunoflouresence (IF) analysis of the localization of Myc-DBC-1. Telomeres are 
marked with TRF1 (371) (red, RRX). DBC-1 is detected with Myc antibodies (9E10) 
(green, Alexa 488). (B) IF analysis showing the localization of DBC-1 to Cajal bodies. 
Coilin is used to detect Cajal bodies (Sigma) (green, Alexa 488). DBC-1 is detected with 
HA antibodies (HA.11) (red, RRX). Lower panels show a field captured with a 63x 
objective. All other fields were captured at 100x. In both (A) and (B) cells were extracted 
with Tx-100 prior to fixation to remove soluble proteins. Upper panels in both (A) and 













Polη and Rad51 are part of a TRF2-independent Apollo complex 
 Peptides identifying Tip48, a member of the Tip60 chromatin 
remodeling complex, were present in the isolated Apollo complex (Fig. 5-
1A). Tip48 was detected by immunoblot in affinity purified extracts 
expressing tagged Apollo and not in extracts expressing a vector control 
(Fig. 5-4B). Tip48 does not, however, directly interact with Apollo by co-IP.  
(Fig. 5-4C). Ku70, Ku80, and HSP 70 were also identified in the Apollo 
pulldown. Since each of these proteins are common contaminants in mass 
spectrometry analysis I did not pursue them further. 
 Several bands visible by Coomassie staining of the isolated Apollo 
complex failed to reveal their identity by mass spectrometry. To determine 
the identities of these bands, I tested by immunoblot for the presence of 
factors in pathways that Apollo might be involved in: ICL repair 
(FANCD2); DNA replication (ATRIP); polη and polι; WRN; BLM; 
homologous recombination (Rad51, Rad51C, BRCA1, BRCA2, Rad54), and 
NHEJ (DNA-PKcs) (Fig. 5-4A-B). Among these proteins, Rad51 and 
polη  were the only proteins that were enriched in the Apollo complex (Fig. 
5-4B). I tested whether these proteins could interact directly with Apollo. As 
previously observed, TRF2 and DBC-1 interact directly with Apollo but not 
TRF1 in co-IP experiments. Co-IP experiments show that polη and Rad51 
do not interact directly with Apollo (Fig. 5-4C). I next tested whether the 
association of Rad51 and polη with Apollo was mediated by TRF2 or Rap1, 
both abundant components of the Apollo complex. In order to test this 
possibility, I used the allele of Apollo that does not bind TRF2/Rap1 
(Chapter 2). Co-IP experiments showed that ApolloΔTRF2 can associate 
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with Rad51 and polη, establishing that these factors interact with the Apollo 
complex in a TRF2-independent manner (Fig. 5-4D).  
 
Figure 5-4: Rad51 and polη  interact with the Apollo complex in a TRF2-
















Figure 5-4: Rad51 and polη  interact with the Apollo complex in a TRF2-
independent manner.  
(A) Immunoblot indicating the presence of polη and Rad51 in the Apollo complex after 
tandem purification using Flag and HA epitopes and not in vector control IPs. (B) 
Immunoblot of extracts for proteins suspected to be in the Apollo complex. IP performed 
tandemly from HeLa S3 cells using Flag and HA epitopes and subsequently blotted for 
the presence of proteins listed on the left. Input (IN), Vector (V), NFHA2-Apollo (N), 
Apollo-FHA2C (C). (C) Co-IP experiment indicating that Rad51 and polη do not interact 
directly with Apollo. HA-Apollo was co-transfected with cDNA encoding Myc-tagged 
proteins listed on the right. Myc IP was performed and immunoblotting of IPs was 
performed with Myc antibodies to verify expression (right) and HA to look for the 
presence of Apollo (left). (D) Immunoblot analysis of polη and Rad51 binding to Apollo 
complexes with (HA-Apollo) and without (HA-ApolloΔTRF2) the presence of 
TRF2/Rap1. 293T cells were transfected with either contruct listed above. The presence 
of the proteins listed on the left in the IPs was analyzed by Immunoblot with antibodies to 
the endogenous protein (except HA). Input is 2.5% of IP. Specific antibodies listed in 











 In this chapter we uncovered interactions of Apollo with DBC-1, polη 
and Rad51 in an Apollo complex that is independent of TRF2. As the Apollo 
complex we isolated contains stoichiometric amounts of TRF2/Rap1, the 
results point to a shelterin subcomplex that contains these factors.  
 Polη and Rad51 have both been implicated in homologous 
recombination, specifically the extension of the D loop structure after 3' 
strand invasion into duplex DNA. In complex with these proteins, Apollo 
might be involved in t-loop formation (discussed further in Chapter 5). 
Curiously, Rad54, a factor shown to promote 3' Rad51 filament invasion 
into duplex DNA, was not recovered in the Apollo IP. 
 The localization of DBC-1 to Cajal bodies and its direct interaction 
with Apollo is highly suggestive of a function for Apollo in telomerase 
recruitment at telomeres. This hypothesis is currently being tested by 
examining the effect of DBC-1 knockdown in a telomerase recruitment 
assay that examines the rate of telomere elongation in Pot1ΔOB expressing 
cells. Additionally, co-IP experiments are being performed with DBC-1 and 
hTERT to test this hypothesis.  
 Apollo has been implicated in ICL repair. ICL repair is a multistage 
process that involves converting an ICL into a DSB, localization of the 
FANCD2-FANCI complex to the site of damage, NER processing, 
homologous recombination, and potentially translesion synthesis and 
chromatin remodeling. Factors involved in some of these processes have 
been isolated in the Apollo complex. However, due to the diverse pathways 
these proteins are involved in, we are unable to place Apollo in a specific 
stage of ICL repair.  
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CHAPTER 6: DISCUSSION 
Preamble 
 The most important function of a telomere is to prevent the 
chromosome end from being recognized as a break and processed 
inappropriately by DNA repair enzymes. Telomeres fulfill this role by 
providing a platform of telomere repeats onto which specific telomere DNA 
binding proteins can load to form a protective cap.  The telomere can ensure 
its maintenance by regulating telomerase with its binding proteins. In 
mammals, shelterin performs this protective role with its six protein 
components. Shelterin recruits telomere accessory factors to shape the 
telomere structure. Paradoxically, the enzymes and proteins that shelterin 
recruits have activities that shelterin is meant to protect against, such as non-
homologous end joining and homologous recombination. This implies a 
tightly regulated interaction between shelterin and factors involved in DNA 
transactions.  
 In this thesis I describe the identification of a new shelterin accessory 
factor, Apollo. Apollo is recruited to telomeres by TRF2 and it interacts with 
TRF2 on a molecular surface that other telomere accessory factors are 
predicted to bind. Abolishing this interaction or reducing the amount of 
endogenous Apollo by shRNA results in telomere dysfunction in S-phase. 
Our findings suggest that Apollo has a role in telomere replication, the 
generation of ssDNA at the telomere, and potentially a role in t-loop 
formation and regulation of telomerase. In this discussion I will briefly 




Apollo localizes to telomeres and interacts with TRF2 
 In our efforts to find TRF2/Rap1 binding partners we discovered an 
interaction with hSNM1B/Apollo, a member of the β-CASP family of 
nucleases. Apollo was identified in the affinity purified TRF2/Rap1 complex 
by mass spectrometry. Apollo was found to interact directly with the TRFH 
domain of TRF2 through co-IP experiments. Consistent with co-IP data, ITC 
measurements show a strong binding of Apollo with TRF2-TRFH (Kd, 0.12 
µM). Although the TRFH domains of TRF1 and TRF2 are nearly identical 
structurally, Apollo does not interact with TRF1. To understand why Apollo 
interacts specifically with TRF2 and not TRF1, structural analysis was 
performed with a peptide from the C terminus of Apollo (aa498-509) and the 
TRFH domain of TRF2. Analysis of this interaction revealed that the folding 
of alpha helices 2 and 3 in TRF1-TRFH does not provide space for Apollo 
residues L500 and Y504. Tin2 can bind to the same molecular surface as 
Apollo in TRF2-TRFH yet with a Kd of 6.5 µM. The specific strong 
interaction with TRF2 by Apollo and not Tin2 can be partially explained by 
the electrostatic interactions made by Y504, whereas Tin2 has a 
phenylalanine at the equivalent position. A putative motif for interaction 
with the TRFH domains in TRF1 and TRF2 in the loop between alpha helix 
3 and 4 arose from this study where TRF1 binding proteins have an FxLxP 
motif and TRF2 interacting proteins have an YxLxP motif. As explained in 
Chapter 2, the L and P position of Tin2 and Apollo bind in an almost 
identical manner. Consistent with this finding, many known TRF2 
interacting factors contain an YxLxP motif.  
 Using this information we can examine how much of the protective 
function of TRF2 at telomeres is mediated by accessory factors. It will be 
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interesting to look at the phenotypes of TRF2 deficient MEFs rescued with 
the TRF2 point mutation that cannot bind to Apollo and potentially a set of 
other repair proteins (TRF2F120A). Are telomere accessory factors in 
competition for this single binding site in TRF2? Or does the multimeric 
organization of TRF2 offer enough binding sites for all of the enzymes and 
proteins predicted to bind to TRF2? Because of the tight binding of Apollo 
to TRF2 (Kd, 0.12 µM), one might expect Apollo to be an effective 
competitor for TRF2 binding with other accessory factors in a setting where 
Apollo is overexpressed. Cells readily overexpress Apollo and these cells do 
not have any phenotypes associated with defects at the telomere by FISH 
and TIF analysis. However, there is a decrease in the amount of ssDNA at 
the telomere in cells that overexpress Apollo. In this setting, Apollo might 
occupy the TRF2-TRFH binding site of a protein required for the regulation 
of ssDNA at the telomere, Mre11, for example.  
 When overexpressed, Apollo localizes to most telomeres in individual 
cells and at telomeres throughout the cell cycle in primary and tumor cell 
types. This observation indicates that the localization of Apollo to telomeres 
is not cell cycle regulated and that Apollo could act at most telomeres within 
a cell. Due to lack of an antibody we were unable to track endogenous 
Apollo at telomeres. It is possible that the localization of endogenous Apollo 
at telomeres is cell cycle regulated or its protein levels are cell cycle 
regulated. Until an antibody that recognizes endogenous Apollo is made, 
real time PCR methods can be used to determine whether the transcription of 
Apollo mRNA is cell cycle regulated.  
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DNA damage response occurs at telomeres in the absence of Apollo 
 In Apollo knockdown cells, telomeres are dysfunctional and the DNA 
damage factors γH2AX and 53BP1 localize to telomeres. These TIFs arise 
specifically in S-phase, indicating that they are a result of aberrant 
replication of telomeres or the presence of an inappropriate structure after 
telomere replication. The nature of the TIFs has not been examined. This 
will be critical to understanding what type of damage is being sensed in the 
absence of Apollo. If ICLs are being sensed, proteins involved in ICL repair 
such as the ID complex (FANCD2 and FANCI) and homologous 
recombination proteins like BRCA1, BRCA2 will be present at TIFs. If the 
lesions are Thymine dimers one would expect to find NER proteins localized 
to TIFs. If the damage is due to stalled or collapsed replication forks, ATR 
and RPA might be present. Consistent with a telomeric DNA damage 
response, human primary cells with reduced levels of Apollo have a growth 
arrest, senescent morphology, an induction of the CDK inhibitor p21, and 
stain positive for SA-β-galactosidase. However, this growth defect is largely 
rescued by the expression of ApolloΔTRF2. This finding implies two 
possibilities. Either Apollo deficiency in a non-telomeric role is the cause of 
the growth defect seen in Apollo knockdown cells or alternatively, 
ApolloΔTRF2 might still bind minimally to telomeres. A large fraction of 
Pot1 was recovered in the Apollo complex. A few molecules of Apollo 
might associate with Pot1 at the telomere terminus and regulate ssDNA but 
cannot bind along the length of telomeres (hence the absence of telomere 
foci in cells that overexpress ApolloΔTRF2).  
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Telomeres are sensitive to Aphidicolin treatment 
 Treatment with low doses of Aphidicolin slows replication and 
induces the expression of common fragile sites as evidenced by chromosome 
breaks and SCEs. Fragile sites are classified as rare or common, based on 
their induction and frequency within the population. Rare fragile sites often 
have a proximal expansion of repeat sequences 216. For example, the rare 
fragile site FRA16B has a block of telomere-like repeats adjacent to it 217. In 
wildtype cells and cells treated with Apollo shRNA, T-SCEs occurred at a 
large proportion of telomeres after treatment with low doses of Aphidicolin 
(9-10%). This finding corroborates work from K. Hoke showing a high 
incidence of TIFs in MEFs after Aphidicolin treatment (K. Hoke and T. de 
Lange unpublished results). This provides evidence that telomeres are 
challenging templates to replicate and are induced like fragile sites upon 
Aphidicolin treatment. Yet, in contrast to telomeres, fragile sites are often 
late replicating. The sensitivity of telomeres to Aphidicolin might be due to 
secondary DNA structures like G-quadruplexes or the susceptibility of 
telomeres to DNA lesions.  
Multiple telomere signal phenotype of Apollo knockdown cells is 
replication related 
 In cells with reduced levels of Apollo and in cells expressing 
ApolloΔTRF2, we observed a significant increase in the incidence of 
multiple telomere signals on a single chromatid end. The frequency of these 
aberrations is increased when Apollo knockdown cells are treated with 
Aphidicolin, suggesting they are replication related. What do these structures 
represent? The FISH signal we observe on a chromatid with multiple signals 
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is roughly the sum of the sister signal, indicating that there is no loss or gain 
in the telomeric DNA content. This diminishes the possibility that these 
structures represent stalled or reversed replication forks at the telomere. 
Additionally, substantial telomere loss is not observed in cells with 
diminished levels of Apollo. Finally, our data suggests that these structures 
are not recombined t-loops still attached to telomeres.  
 A telomere transcript (termed telomeric repeat-containing RNA 
(TERRA)) ranging in size from 100 bp and 9 kb has recently been reported 
to localize to telomeres 218. The function of this RNA at telomeres is not 
known but its presence appears to be negatively regulated by the nonsense 
mediated messenger RNA decay pathway 218. Considering the putative RNA 
metabolizing domain in Apollo, Apollo might be involved in regulating 
TERRA at telomeres. The multiple telomere signals we observe might be a 
result of detection of TERRA at telomeres. Apollo might be required to 
process TERRA to allow the replication fork to pass. To test the possibility 
that Apollo is involved in regulating TERRA, the localization and 
abundance of TERRA can be followed using an RNA probe in settings with 
different levels of Apollo. 
 It is unknown what fraction of telomeres form t-loops. G-quadruplex 
structures have been suggested to protect telomeres from degradation. These 
structures might form on chromosome ends that do not form t-loops. If 
Apollo deficient cells, or cells expressing ApolloΔTRF2 are impaired in 
their ability to form t-loops, G-quadruplex structures might form with a 
greater frequency. This might explain the multiple telomere signals seen in 
wild type cells and the moderate increase of these signals seen in Apollo 
deficient cells.  
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 Preliminary CO-FISH analysis of the multiple telomere signals 
showed that Apollo loss affects both sister telomeres generated by leading or 
lagging strand DNA synthesis. However, the total number of multiple 
telomere signals observed in wildtype and Apollo knockdown cells was 
reduced compared with FISH analysis. These experiments must be 
reexamined to determine whether our reasoning for the potential role of 
Apollo in regulating TERRA or the relative abundance of G-quartets is 
consistent. TERRA is composed of UUAGGG repeats and would be 
detected with the product of leading stand synthesis by CO-FISH. G-
quadruplexes would be detected on the product of lagging strand synthesis 
by CO-FISH.  
Apollo affects the amount of ssDNA at human and mouse telomeres 
 The nuclease(s) that generates the 3' ssDNA overhang after telomere 
replication and defines the 5' end of chromosomes is unknown. We tested 
whether Apollo was involved in these processes.  
 We found that Apollo does not define the sequence of the 5' end of 
chromosomes. As theses studies were performed using a knockdown 
strategy and expression of exogenous proteins, the results are not conclusive. 
It is possible that in the absence of Pot1, attack on the 5' end would occur by 
multiple nucleases, masking the effect of a single nuclease that is normally 
regulated by Pot1.  
 We assayed whether Apollo has a role in the generation or removal of 
ssDNA at telomeres and found that it acts to negatively regulate the amount 
of ssDNA at human telomeres. Overexpression of Apollo and ApolloΔN in 
human cells resulted in less ssDNA at the telomere, whereas overexpression 
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of ApolloΔTRF2 increased the amount of ssDNA. This data suggests that 
Apollo negatively regulates ssDNA at telomeres. This could occur by 
preventing 3' overhang extension, preventing 5' end resection, or by 
promoting 3' end degradation. In an Apollo knockdown setting, there was no 
change in the amount of ssDNA at the telomere. These results suggest that in 
a knockdown setting there is sufficient Apollo at the telomere to regulate the 
amount of ssDNA at the telomere, whereas ApolloΔTRF2 might act as a 
dominant negative allele.  
 We examined the effect of Apollo knockdown on 5' end resection in 
mouse cells after removal of Pot1b. In this setting, Apollo promotes 5' end 
resection as the amount of ssDNA was reduced after Pot1b removal in 
Apollo knockdown cells. As Apollo knockdown does not have an effect on 
the overhang in Pot1b proficient cells, it is difficult to interpret this finding.  
Apollo might be one of many nucleases that act in 5' end resection, all 
regulated by Pot1b. Examination of the 3' overhang in Pot1b-/- Apollo-/- 
MEFs will show whether Apollo is the principal nuclease involved in 5' end 
resection.  
The negative and positive affects of Apollo on ssDNA generation can be 
reconciled in the following model. In Pot1 proficient cells, the action of 
Apollo at the 3' end is regulated by TRF2 and Pot1 (Fig. 6-1C). Pot1 acts to 
promote 5' resection at the telomere terminus in conjunction with Apollo. 
When ApolloΔTRF2 is overexpressed in Pot1 proficient cells, Apollo can 
still associate with Pot1 at the telomere terminus, unregulated by TRF2. This 
inappropriate association might lead to increased amounts of ssDNA at the 
telomere by increased 5' end resection (Fig. 6-1D). In Pot1 deficient cells, 
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Apollo , and potentially other nucleases, bound to TRF2 would act to resect 
the 5' end of telomeres (Fig. 6-1E).  
   
Figure 6-1: Apollo affects the amount of ssDNA at mammalian telomeres 
(A) In this model TRF2 binds to newly replicated telomeres. (B) Apollo is recruited to 
TRF2 and participates in generating the 3' overhang. (C) POT1 binds to ssDNA 
preventing further resectioning by inactivating Apollo. (D) Excessive 5' resectioning is 
observed when an allele of Apollo that can no longer bind to TRF2 (ApolloΔTRF2) is 
expressed. (E) In the absence of Pot1b in mouse cells, Apollo participates in excessive 
resectioning of the 5' end. In summary, the presence of both TRF2 and POT1 are required 
to prevent inapproriate resection at the telomere by Apollo.  
 
 This model can be further tested by discovering and perturbing the 
connection between Apollo and Pot1b. We would expect that overexpressing 
a mutant form of Apollo that can no longer bind to Pot1b (ApolloΔPot1b) 
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would result in excessive resection at the telomere whereas the 
overexpression of the double mutant, ApolloΔTRF2ΔPot1b, would not affect 
the resection of the 5’ end.   
Apollo interacts primarily with TRF2/Rap1 
 In the isolated Apollo complex, Apollo, TRF2, and Rap1 are present 
in roughly equal stoichiometry. This leads to the possibility that Apollo is a 
resident telomere-specific nuclease kept exclusively in complex with 
TRF2/Rap1. Also, exogenous Apollo does not relocate from telomeres to 
sites of DNA damage, indicating that Apollo might not play a role in 
telomere unrelated pathways. However, two points of evidence argue against 
an exclusive role at telomeres for Apollo. The first is that non-telomeric 
DNA damage foci in Apollo knockdown cells can be partially rescued by 
ApolloΔTRF2. Secondly, ApolloΔTRF2 expression largely rescues the 
growth defect observed in Apollo knockdown cells, suggesting that loss of 
Apollo in non-temoleric roles is detrimental for the cell. These data indicate 
that Apollo performs essential functions in the cell independently of 
TRF2/Rap1. Apollo has been implicated in ICL repair as Apollo knockdown 
cells show sensitivity to ICL agents 138 139.  
Apollo has a direct interaction with DBC-1 which localizes to Cajal 
bodies 
 Apollo interacts with DBC-1 in co-IP experiments. This interaction is 
unique to Apollo, as DBC-1 does not directly interact with shelterin. In this 
work, we find that the principal localization of DBC-1 in the nucleus is in 
Cajal bodies. The telomerase RNA subunit, hTR, has been recently shown to 
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accumulate in these subnuclear structures. Cajal bodies are not required, 
however, for the enzymatic activity of telomerase and are instead implicated 
in the recruitment of telomerase to telomeres. In the simplest model, Apollo 
would be required to resect the 5' end after telomere replication to generate a 
primer for telomerase (Fig. 6-2B). DBC-1 would then bind to Apollo and 
situate telomerase on the 3'end (Fig. 6-2C). An interaction between TPP1 
and hTERT has been reported and TPP1 bound to Pot1 increases the 
proccessivity of telomerase in vitro 74 73. These two pathways, recruitment of 
telomerase and stimulation of telomerase, could act together to ensure the 




















Figure 6-2: Model for telomerase recruitment to human telomeres.  
(A) TRF2 binds to telomeres after replication and (B) recruits Apollo and other nucleases 
which participate or facilitate 5' resectioning of chromosome ends. (C) Considering the 
localization of DBC-1 to Cajal bodies and the direct interaction of Apollo with DBC-1, 
DBC-1 might mediate the recruitment of telomerase to telomeres. (D) POT1/TPP1 bind 
to ss-DNA and stimulate telomerase processivity after telomerase recruitment through a 






 This model predicts that DBC-1 deficient cells would have a telomere 
shortening phentoype in telomerase positive cells. We are currently testing 
DBC-1 in a telomerase recruitment assay that takes advantages of the rapid 
elongation of telomeres observed in cells that overexpress Pot1ΔOB 
{Loayza and de Lange, 2003, Nature, 424, 1013-8}. If DBC-1 is important 
for the recruitment of telomerase to telomeres, knockdown of DBC-1 in this 
assay will result in reduced telomere elongation in Pot1ΔOB expressing 
cells.  
Factors involved in D loop extension are part of the Apollo complex 
 Homologous recombination has been proposed to shape the telomere 
into a t-loop conformation 16. Work presented in this thesis describes Rad51 
and polη as part of the Apollo complex. Polη has been found to extend D 
loops in vitro, possibly through recruitment by Rad51212. Apollo, Rad51, and 
polη could cooperate in the following model: To form a t-loop, the Apollo 
complex is recruited after replication to resect the 5' end and form a transient 
Rad51 filament on the exposed 3' end (Fig. 6-3B). Further steps would 
include invasion of the 3' end into duplex telomeric DNA (Fig. 6-3C). Polη 
would act to extend the 3' end in the D loop and thereby stabilize the 
structure (Fig. 6-3D). Apollo might regulate this step so as not to allow polη 
to extend the 3' overhang too far. This regulation step might explain the 
increase in telomeric ssDNA observed after expressing ApolloΔTRF2. After 




Figure 6-3: Model for t-loop formation.  
(A) TRF2 binds to telomeres after replication and (B) recruits Apollo and other nucleases 
to resect the 5' end of chromosomes. In this model, Rad51 forms a transient filament on 
newly generated ssDNA. (C) The Rad51 filament facilitates invasion of the 3' end into 
ds-DNA, generating a displacement loop (D loop). (D) Through a direct interaction with 
Rad51, polη is recruited to extend and stabilize the D loop. Pot1 would displace the 
Rad51 on ss-DNA after t-loop formation due to its higher affinity for telomeric DNA (not 
shown).  
 
 Rad51 has been reported to be at telomeres in late S/G2 in ChIP 
experiments 219. However, in these experiments cells were synchronized 
with Aphidicolin. As I show in Chapter 4, Aphidicolin induces a high 
incidence of DNA damage at telomeres and this would recruit Rad51 to 
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telomeres specifically in response to this drug. The findings of Verdun and 
Karlseder may therefore not be applicable to normal telomere metabolism. I 
tried unsuccessfully to ChIP polη and Rad51 at telomeres in settings with 
different levels of Apollo. These experiments are worth pursuing to 
understand if Apollo associates with these proteins for activities at the 
telomere and to determine whether their recruitment to the telomere is 
dependent on Apollo.  
 The model presented above predicts that t-loop formation and 
stabilization would be impaired in cells deficient for either polη or Apollo. It 
will be interesting to look at t-loops isolated from Apollo null mouse cells 
and see whether Apollo has a role in their formation or maintenance. 
Additionally, the overhang in polη deficient XP-V cells can be examined 
and would be expected to be shorter. Finally, if the Rad51 filament invades 
the subtelomere to form a t-loop, sequences from this region will be used as 
a template for extension of the 3' end in the D loop by polη. The sequence of 
the 3' overhang can be examined for the presence of non-canonical telomere 
repeats.  
Diversity in SNM1 gene number 
 As discussed in Chapter 2, there are three SNM1 genes in vertebrates 
involved in diverse processes such as ICL repair, NHEJ, hairpin opening 
activity during V(D)J recombination, and as described in this thesis, 
telomere metabolism. We examined the number of SNM1 genes in other 
organisms to glean insight into the age of these genes and to understand 




  At the root of the phylogenetic tree presented in Fig. 6-4, the ciliate 
Tetrahymena thermophila and the plants Arabidopsis thaliana and Oryza 
sativa (not shown) have three SNM1 genes. This suggests that a common 
ancestor required the function of three SNM1 genes. Alternatively, it could 
suggest that both of these branches evolved to require the presence of three 
SNM1 genes. Presumably the processes of NHEJ and ICL repair would 
require the presence of at least two SNM1 genes. It will be interesting to see 
whether the third gene is involved in telomere metabolism in these 
organisms.  
 Diversity in the number of SNM1 genes is seen in Fungi. Both 
budding and fission yeast have only one SNM1 gene, wheras Neurospora 
crassa, Candida albicans (not shown) and Apergillus fumigatus have two. 
The single SNM1 gene in S. cerevisiae and S. pombe is required for ICL 
repair. The Mre11 nuclease appears to take the place of Artemis in S. 
cerevisiae during NHEJ, and might take have removed the requirement for a 
SNM1 gene in this process. Furthermore, Artemis is active in conjunction 
with DNA-PKcs, a PIKK kinase absent from the S. cerevisiae and S. pombe 
genomes. Again, it will interesting to see whether the yeast species with two 
SNM1 genes use one in telomere maintenance. 
 There are also a diverse number of SNM1 genes in metazoans. 
Vertebrates and Echinoderms have three separate genes whereas, the 
arthropod Drosophila melanogaster has a single gene and the nematodes 
Caenorhabditis elegans and Caenorhabditis briggsae have one and two 
genes, respectively. In Caenorhabditis briggsae, the two genes are very 
similar (~70% identity) and might represent a recent gene duplication event 
after the initial loss of two SNM1 genes. Interestingly, the SNM1 proteins in 
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nematodes are a fusion of an N-terminal OB fold (a single-stranded DNA 
binding motif also found in POT1) and a C-terminal metallo-β-lactamase 
domain. It has been recently reported that C. elegans have both G-rich and 
C-rich overhangs at their chromosome ends {Raices et al., 2008, Cell, 132, 
745-57}. This novel combination of  a metallo-β-lactamase domain and a ss-
DNA binding domain might be involved in this unique processing event. 
 
Figure 6-4. Diversity in SNM1 gene copy number.  
Phylogenetic tree listing representative organisms and the number of SNM1 genes 
present in their genome with corresponding NCBI accession numbers. Branching is not 
drawn to scale.  
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 It appears that there were orignially three SNM1 genes and Fungi and 
some Metazoans (arthropods and nematodes) lost one or two copies during 
their evolution. The process of recombinatorial assembly of lymphocyte 
receptors in adaptive immunity, which requires Artemis, did not arise until 
the class Agnatha (jawless fish). In classes that predate the evolution of 
adaptive immunity, a gene was likely required for the NHEJ repair pathway. 
In S. cerevisiae and S. pombe, the single SNM1 gene is required for ICL 
repair. In vertebrates, this role is primarily performed by SNM1A. The 
presence or absence of a third SNM1 gene, like Apollo in mammals, might 
reflect different strategies in solving problems related to telomere 
maintenance. 
Apollo and disease 
 Mutations in DNA repair proteins underlie many cancer 
predisposition syndromes in humans. Mutations in telomere accessory 
factors such as Mre11, Nbs1, ATR, ATM, WRN, XPF, and BLM lead to 
cancer predisposition. Mutations in Artemis, a protein related to Apollo, 
were discovered as the underlying cause of RS-SCID. Mutations in Apollo 
have not been linked to human disease. Perhaps because most Apollo 
mutations are predicted to be lethal, mutations leading to a leaky phenotype 
or a disassociation of function might be rare.  
 We cannot presently ascribe a precise function to Apollo at the 
telomere. In this thesis, we have shown that Apollo is involved in the 
protection of telomeres during or after replication, generation of ssDNA at 
the telomere, and potentially in t-loop formation and telomerase regulation. 
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MATERIALS AND METHODS 
 
Cell culture 
IMR90 primary lung fibroblasts (ATCC), HeLa, p53-/- and SV40 
transformed MEFs, 293T cells, Phoenix ecotropic and amphotrophic 
packaging cell lines were grown in DMEM supplemented with 100 U/ml 
penicillin (Sigma), 0.1 µg/ml of streptomycin (Sigma), 2.0 mM L-glutamine 
(Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), and 10% Fetal 
Bovine Serum.  BJ fibroblasts (Clontech) and BJ-hTERT were grown in 4:1 
DMEM/199 media supplemented with 15% fetal bovine serum, 100 U/ml 
penicillin (Sigma), 0.1 µg/ml of streptomycin (Sigma), 2.0 mM L-glutamine 
(Invitrogen), 0.1 mM non-essential amino acids (Invitrogen), and 1 mM 
sodium pyruvate (Sigma).  All cells were grown at 37°C, 5% CO2, and 95% 
relative humidity.  Cells were passaged by pre-rinsing with room 
temperature PBS followed by incubation in Trypsin-EDTA (Gibco, 0.25%) 
for 2-5 min.  Cells were seeded as indicated in text.  Cells were counted with 
a Counter Counter Z1 Particle counter.  For growth curves, 300,000 cells 
were plated on a 10 cm dish and grown for 72 hrs.  Cells were harvested 
using trypsin and recovered in 4 ml of media, and the total cell number was 
determined.  300,000 cells were plated in a new 10 cm dish.  At specified 
times, extra cells were plated in order to obtain protein and DNA samples 
for analysis.  Population doublings were determined by the following 




Calcium phosphate transfection of 293T cells for IPs and co-IPs  
16-24 hrs. prior to transfection, 3-4 x 106 293T cells were plated in 10 cm 
dishes. Cells were transfected with 10 µg total DNA of the appropriate 
plasmids using CaPO4 coprecipitation.  For each plate, 428 µl H20, 62 µl  
2M CaCl2, and 10 µg total plasmid DNA was mixed with an equal amount 
of 2X HBS (50 mM HEPES pH 7.05, 10 mM KCl, 12 mM dextrose, 280 
mM NaCl, 1.5 mM Na2PO4) while being mixed by blowing air through a 2 
mL pipette with a Pipet-aid (Drummond).   Media was refreshed 5-8 hrs. 
after transfection.  48 hrs. after transfection, cells were harvested in media, 
counted, washed with PBS, and resuspended in 200-500 µl of lysis buffer 
(50 mM Tris-HCl pH 7.4, 1% Triton X-100, 0.1% SDS, 150 mM NaCl, 1 
mM EDTA, 1 mM DTT, 1 mM PMSF, with a complete mini-protease 
inhibitor tablet [Roche] per 10 ml). The NaCl concentration was raised to 
400 mM, and the lysate was incubated on ice for 5 min. The NaCl 
concentration was reduced to 200 mM with an equal volume of cold water, 
cell debris was removed by centrifugation at 13K for 10 min. at 4°C.  
Immunoprecipitations 
For immunoprecipitation of proteins expressed by transient transfection in 
293T cells, transfection and harvesting was performed as above.  50 µL of 
2X Laemmli buffer was added to 50 µL of lysate and set aside as the 
“Input.”  Antibody (anti-FLAG (M2), 4–6 µg; anti-HA (HA.11),1.0–1.2 µg; 
antimyc (9E10, Oncogene), 0.6–1.0 µg) was added to 800 µL of lysate.  
Samples were nutated at 4°C for 5 hrs.  60 µL of a Protein G sepharose 
slurry (50% [v/v] Protein-G sepharose [Amersham] in PBS in 1 mg/ml 
BSA) were added and samples were nutated at 4°C for an additional 60 min.  
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Beads were washed 4 times at 4°C with lysis buffer, and 
immunoprecipitated protein was eluted with 60 µL 2X Laemmli buffer. 
Samples were boiled for 5 min before loading onto SDS-PAGE gels.  
Retroviral gene delivery 
16-24 hrs. prior to transfection, 3-4 x 106 Phoenix packaging cells (293T 
derived cell lines) were plated in 10 cm dishes.  For infection of mouse cells, 
Phoenix ecotropic cells were used.  For infection of human cells, Phoenix 
amphotropic cells were used.  Phoenix cells were transfected with 20 µg of 
the appropriate plasmid DNA by CaPO4 coprecipitation (described above).  
The media was refreshed 5-8 hrs. later, and again 24 hrs. later.  36 hrs. after 
transfection, media was filtered through a 0.4 µm filter and polybrene was 
added to a final concentration of 4 µg/mL.  Fresh media was added to the 
virus producing cells.  This procedure was repeated 3 additional times at 12 
hr. intervals.  If appropriate, 12 hrs. after the final infection, fresh media was 
added containing antibiotics for selection (puromycin 2 µg/ml, hygromycin 
90 µg/ml) for 3-8 days until uninfected control cells were completely dead. 
Cell synchronization 
HeLa cells (1 x 106) were plated on coverslips in a 10 cm culture dish and 
treated with 2 mM thymidine 24 h later. After 14 h, cells were washed three 
times with prewarmed PBS and provided with fresh medium for 11 h before 
adding 2 mM final concentration of thymidine. After 14 h, cells were 
washed with prewarmed PBS and again provided with fresh medium. Cells 
were harvested at the indicated time points for immunoblotting. 
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Expression of Cre Recombinase 
Cre was introduced into MEFs using pMMP Hit & Run Cre-GFP retrovirus 
or pWZL-Cre retrovirus (containing the hygromycin resistance gene) using 
the retroviral infection technique described above. 
Isolation of clonal lines 
HeLa S3 cells expressing FHA2-Rap1 were plated at low density (500-2000 
cells/10 cm dish) and grown for approximately 2 weeks until clonal 
populations were visible under the light microscope.  Clonal populations of 
cells were isolated by trypsinizing cells in cloning cylinders.  Clonal 
populations were transferred to a well of a 96 well plate.  When the cells 
reached confluence in the well, the clonal population was expanded. 
Purification of the TRF2/Rap1 and Apollo complexes 
For isolation of TRF2/Rap1 complexes from HeLaS3 cells, two retroviral 
vectors based on pLPC were generated by introducing a FLAG-HA-HA tag 
(FH2) in a N- or C-terminal position. Human Rap1 
cDNA was PCR-amplified and cloned separately into either the N or C 
terminally tagged constructs and sequenced. Apollo (SNM1B) cDNA was 
obtained from Invitrogen, and tagged versions of Apollo were generated by 
using standard PCR cloning into the pLPC retroviral vectors. 
These constructs were transfected into amphotrophic Phoenix cells using 
calcium phosphate and the retroviral stocks were prepared for infection of 
semi-adherent HeLaS3 cells. Clones expressing tagged hRap1 were selected 
using puromycin (2  µg/ml) and isolated with cloning cylinders. The 
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efficiency of N- and C-terminally tagged hRap1 in forming a complex with 
endogenous TRF2, were tested by co-immunoprecipitations (IP). 
HeLa S3 clones that expressed tagged hRap1 at a level 1-2-fold above 
that of endogenous hRap1 protein were selected for purification. For 
isolation of the TRF2/Rap1 and Apollo complexes, cells were grown in 
suspension culture (10 liters) at 37 °C to a density between 1.5-1.8 x 106 
cells/mL. Cell harvest, extraction of nuclear proteins, sequential binding to 
affinity matrix, and peptide elutions were performed according to published 
procedures (Ogawa et al. 2002, Science) except that commercial affinity 
resins were used (anti-FLAG M2 resin from Sigma and anti-HA 3F10 resin 
from Roche). Eluted proteins were separated by SDS-PAGE on home made 
gradient gels (5%–15%). Coomassie staining was performed using Colloidal 
Blue Kit (Invitrogen) and silver staining was performed using the 
SilverQuest kit (Invitrogen). 
Mass Spectrometry  
In collaboration with the Chait Lab 
The entire gel lane was sliced into 29 2-mm pieces, and the proteins in each 
gel piece were subjected to trypsin digestion. The resulting peptides were 
extracted and the proteins identified using a combination of two different 
mass spectrometers. First, tryptic mass maps of proteins from each gel piece 
were obtained using an in-house-constructed MALDIQqTOF mass 
spectrometer, and second, fragmentation spectra of all the discernable tryptic 
peptides were obtained using an in-house-constructed MALDI-ion trap 
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mass spectrometer (Krutchinksy et al. 2000, Anal Chem; Krutchinsky et al. 
2001, J. Am. Soc. Mass Spectrom). Accurate masses of the tryptic peptides 
and the masses of their fragments were used to identify proteins in each gel 
piece with the computer search engine XProteo. 
Rockefeller University Proteomics Resource Center 
To identify Apollo and to examine the Apollo complex, individual bands 
were excised and subjected to trypsin digestion. The resulting peptides were 
extracted, and the protein was identified using the Applied Biosystems 
QSTAR XL tandem mass spectrometer at the Rockefeller University 
Proteomics Resource Center. 
shRNA 
shRNAs were generated in pSUPER-retro (OligoEngine), and retroviral 
infections were performed as described. The sequences of the shRNA targets 
are as follows:  
H2, 5′-GAAGCTGCCCACCAGATTG-3′;  
H6, 5′-GACTCTGTACAGCAATACA-3′;  
H7, 5′-GATCAATCTCAAGCTGACA-3′;  
H8, 5′-GATGGAGGTCCAGAAGCCA-3′; and  
UTR, 5′-GGTCCTCGTGCCTATGGAA-3′.  
The Luciferase control hairpin is 5′-CGTACGCGGAATACTTCGA-3′. The 
target sequence of shRNA H6 was changed to 5′-
GACTCCGTCCAACAATACA-3′ by standard site-directed mutagenesis to 




RT-PCR was performed with the oligo-dT ThermoScript RT-PCR system 
(Invitrogen). RNA was isolated from approximately 106 cells with the 
Qiagen RNAeasy kit. Three to four micrograms RNA was reverse 
transcribed with the ThermoScript RT-PCR system (Invitrogen) by using 
oligo dT priming and the protocol provided by the manufacturer. The 
primers used for PCR after cDNA synthesis are as follows: Apollo RT1 
(forward GACTCCAACCCTACCACCATGAATG, reverse 
CAGTAGCTGTACCAACTCCAGGCGC) and GAPDH (forward TGAA 
GGTCGGAGTCAACGGATTTGGT, reverse 
CATGTGGGCCATGAGGTCCACCAC).  
Radiation and drug treatment of cells 
For γ-irradiation, cells were seeded in 6 cm culture dishes and exposed to a 
Ce source.  Cells were allowed to recover in the incubator for the indicated 
amount of time before harvesting.  For UV radiation, media was removed 
and reserved.  Cells were subjected to the indicated dose of UV radiation in 
a Stratalinker 1800 (Stratagene).  Reserved media was added back to cells 
and cells were allowed to recover in the incubator for the indicated amount 
of time before harvesting.  Cells were treated with the indicated amounts of 
aphidicolin (Sigma), hydroxyurea (Sigma), MMC (Sigma), and cisplatin 
(Sigma) for the indicated amounts of time.  
Whole cell lysates and western blots 
For whole cell lysates, cells were harvested, washed with PBS, counted and 
resuspended in 2X Laemmli buffer at a concentration of 10,000 cells/µl.  
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Lysates were boiled for 5 min. and DNA was sheared through a 28 gauge 
insulin syringe.  Protein samples were separated by SDS-PAGE and blotted 
onto nitrocellulose membranes.  Membranes were blocked in 5% milk in 
PBST (0.5% Tween-20 in PBS) for 30 min. at RT and nutated with primary 
antibodies in 5% or 0.1% milk in PBST overnight at 4°C.  Membranes were 
washed 3 times in PBST, nutated in secondary antibody in 5% milk in PBST 
for 45 min. at RT, and washed 3 times with PBST at RT.  ECL (Amersham) 
was applied to membranes for 10 min. before exposure to film. 
Fluorescence activated cell sorting (FACS) analysis 
Cells were harvested from a 10 cm dish by trypsinization, washed with PBS, 
and resuspended in 100 µl PBS.  Two ml ice cold 70% ethanol was added 
dropwise while vortexing.  Cells were stored at 4°C.  For FACS, cells were 
resuspended in propidium iodide solution (500 µl PBS, 100 µg RNase, 25 µg 
propidium iodide) and incubated at RT for 30 min.  Cells were analyzed on a 
Becton Dickinson FACS – Scan II. 
Immunofluorescence 
Cells were plated in dishes on coverslips.  Cells were rinsed with PBS, fixed 
with 2% paraformaldehyde in PBS for 10 min. at RT, wash twice with PBS 
for 5 min.  Cells were either stored in PBS with the addition of 0.02% azide 
or processed immediately. If extraction was desired, prior to fixation, cells 
were treated with Triton X-100 extraction buffer (0.5% Triton X-100, 20 nM 
HEPES-KOH pH 7.9, 50 mM NaCl, 3 mM MgCl2, 300 mM sucrose).  
Extracted cells were fixed with 3% paraformaldehyde, 2% sucrose for 10 
minute at RT, and washed twice with PBS.  Cells were permeabilized with 
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Triton X-100 buffer after fixation.  After permeabilization, cells were 
washed three times with PBS and blocked with PBG (0.2% (w/v) cold water 
fish gelatin (Sigma), 0.5% (w/v) BSA (Sigma) in PBS) for 1 hr. at RT.  Cells 
were incubated with primary antibody diluted in PBG 2 hrs at RT or 
overnight at 4°C, washed 3 times with PBG at RT, incubated with secondary 
antibody diluted 1:250 in PBG for 1 hr. at RT, and washed 3 times with 
PBS.  To the second PBS wash 0.1 µg/ml 4,6-diamidino-2-phenylindole 
(DAPI) was added.  Coverslips were sealed onto glass sides with embedding 
media (ProLong Gold Antifade Reagent, Invitrogen). 
BrdU-TIF analysis 
For the analysis of the cell-cycle stage of TIF induction, IMR90 cells were 
pulsed with 10 μM BrdU for 3 hr, fixed in 3% paraformaldehyde, and 
stained first for TRF1 and 53BP1 and then with rabbit-RRX (Jackson), 
mouse-Cy5 (Molecular Probes), and rat anti-BrdU conjugated to FITC 
(Axyll) in a buffer containing 10% goat serum, 3 mM MgCl2, and 100 U/ml 
DNaseI. 
Metaphase spreads 
Cells were grown to approximately 40% confluence on 10 cm dishes and 
incubated for 1-2 hrs. in 0.1 µg/ml colcemide (Sigma).  Cells were harvested 
by trypsinization, centrifuged at 1K for 5 min., and resuspended in 0.075M 
KCL prewarmed to 37°C.  Cells were incubated at 37°C for 15 min. with 
occasional inversion.  Cells were centrifuged at 1K for 5 min. and 
supernatant was decanted.  Cells were resuspended by tapping in the 
remaining (~200 µl) supernatant.  500 µl of cold 3:1 methanol:glacial acetic 
 
137 
acid fixative was added dropwise while cells were mixed gently on a 
vortexer (<1000 rpm).  Another 500 µl fixative was added slowly while cells 
were being mixed.  Tubes were then filled to 10 mL with the fixative and 
stored at 4°C overnight or longer.  Cells were centrifuged at 1K rpm for 5 
min. and supernatant was decanted.  Cells were resuspended in the 
remaining fixative (~300 µl) and dropped from approximately 6 inches onto 
glass slides which had been soaked in cold water.  Slides were washed with 
fresh fixative and placed on a humidified heating block set to 70°C (42°C 
for CO-FISH) for 1 minute.  Spreading efficiency was checked under a light 
microscope. Slides were dried overnight.  If only DAPI staining was 
required, slides were rehydrated in PBS for 5 min., stained with DAPI in 
PBS for 5 min., washed in PBS for 5 min., and allowed to dry before 
mounting. 
CO-FISH 
For CO-FISH cells were grown in the presence of BrdU:BrdC (3:1, 10 µM 
final) for 12-14 hrs. and supplemented with 0.1 µg/ml colcemide (Sigma) for 
the final two hrs.  Metaphases were harvested as described above.  Cells 
were treated with 0.5 mg/ml RNase A (in PBS, DNase free) for 10 min. at 
37°C.  Slides were then stained with 0.5 µg/ml Hoechst 33258 (Sigma) in 
2X SSC for 15 min. at RT.  Slides were then exposed to 365-nm UV light in 
a Stratalinker 1800 UV irradiator for 30 min. (equivalent to 5.4x103 J/m2).  
Strands which had incorporated BrdU and BrdC were digested with 80 µl of 
10 units/µl Exonuclease III (Promega) under a coverslip for 10 min. at RT.  
Exonuclease III digestion was repeated.  Slides were washed in PBS and 
dehydrated in an ethanol series:  5 min. each 70%, 85%, 100%, and air dried.  
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Slides were incubated with the TAMRA-TelG 5'-[TTAGGG]3-3' PNA probe 
(Applied Biosystems) diluted 1:5000 in  80 µl of hybridization mix (10 mM 
Tris-HCl pH 7.2, 70% deionized formamide, 0.5% blocking reagent 
[Boehringer Mannheim]) under a coverslip for two hrs. at RT in the dark.  
Slides were washed for several seconds in Wash I (70% formamide, 10 mM 
Tris-HCl pH 7.2, 0.1% BSA).  Slides were incubated with the FITC-TelC 5'-
[CCCTAA]3-3' PNA probe (Applied Biosystems) in hybridization mix as 
described above.  Slides were washed in Wash I twice for 30 min. each with 
a stir bar on a magnetic stir plate.  Slides were then washed three times for 5 
min. each in Wash II (0.1M Tris-HCl pH 7.2, 0.15M NaCl, 0.08% Tween-
20) with a stir bar on a magnetic stir plate.  DAPI was added to the second 
wash.  Slides were dehydrated in an ethanol series:  5 min. each 70%, 95%, 
100%, air dried, and mounted. 
FISH 
FISH was performed according to the same protocol as CO-FISH with the 
following exceptions.  Cells were not incubated with BrdU/BrdC prior to 
collection of metaphase spreads.  After metaphase spreads were dropped, 
slides were placed on a heating block set to 70°C (not 42°C as for CO-
FISH).  Hybridization was only performed with the FITC-TelC 5'-
[CCCTAA]3-3' PNA probe at 1:1000 and slides were placed on a heating 
block set to 80°C for 3 min. to denature DNA. 
IF-FISH 
Cells were plated in dishes with coverslips.  Cells were rinsed with PBS, 
fixed with 2% paraformaldehyde in PBS for 10 min. at RT, washed twice 
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with PBS for 5 min. each.  Cells were either stored in PBS with the addition 
of 0.02% azide or processed immediately.  Coverslips were blocked for 30 
min. in blocking solution (1 mg/ml BSA, 3% goat serum, 0.1% Triton X-
100, 1 mM EDTA in PBS) and incubated for 1 hr. in primary antibody 
diluted in blocking solution.  Cover slips were washed 3 times 5 min. each in 
PBS before incubation in secondary antibody diluted in blocking solution.  
Cover slips were washed 3 times 5 min. each in PBS, dehydrated in an 
ethanol series:  5 min. each 70%, 95%, 100%, and air dried.  Coverslips 
were transferred (cells facing up) to glass slides and 80 µl of FITC-TelC 5'-
[CCCTAA]3-3' (Applied Biosystems) probe at 1:1000 in hybridizing 
solution (70% formamide, 0.5% blocking reagent [Boehringer Mannheim], 
10 mM Tris-HCl pH 7.2) was added.  Slides were placed on a heating block 
set to 70°C for 5 min. and incubated in the dark for 2 hrs. – overnight.  
Coverslips were washed twice for 15 min. in 70% formamide, 10 mM Tris-
HCl pH 7.2 and three times for 5 min. in PBS.  DAPI was added to the 
second PBS wash.  Cover slips were sealed on glass slides with embedding 
media. 
Microscopy and image processing 
Images were captured using an Axioplan II Zeiss microscope with a 
Hamamatsu CCD digital camera using Improvision OpenLab software.  
Images were merged in OpenLab and processed with Adobe Photoshop. 
Preparation of mouse genomic DNA 
Cells were harvested by trypsinization and washed with PBS. 0.5 X 106 cells 
for MEFs and 1 x 106 cells for HeLa cells were resuspended in 50 µl PBS 
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and incubated at 50°C for 5 min.  Using pipette tips with the ends cut off, 50 
µl of 2% agarose (prewarmed to 50°C) was added to each sample, mixed, 
and incubated for 5 min at 50°C. The 100 µl mixture was added to the Bio-
Rad plug cast, incubated at RT for 5 min. and at 4°C for 15 min.  Solidified 
plugs were incubated in 0.5 ml Proteinase K digestion buffer (10 mM Tris-
HCl pH 7.9, 250 mM EDTA pH 8.0, 0.2% sodium deoxycholate, 1% sodium 
lauryl sarcosine, and 1 mg/ml fresh Proteinase K) overnight at 50°C.  Plugs 
were washed three times with TE for one hr. each at RT with nutation.  
Plugs were washed for 1 additional hr. at RT with TE containing 1 mM 
PMSF and stored at 4°C in this final wash.  Prior to digestion, plugs were 
washed for 1 hr. in fresh TE and 20 min. in H20.  Plugs were equilibrated for 
1 hr. in the appropriate restriction enzyme buffer at RT.  Each plug was then 
digested with 60 units of MboI for MEFs and 60 units of MboI and 60 units 
AluI for human cells overnight at 37°C.  Plugs were washed with TE for 1 
hr. and equilibrated in 0.5X TBE for 30 min. 
In gel hybridization to detect telomeric DNA from MEFs 
DNA from MEFs was fractionated on a CHEF-DRII PFGE (Biorad) in a 1% 
agarose gel in 0.5X TBE for 24 hrs. at 6 V/cm at 14°C.  Gels were stained 
with ethidium bromide and photographed.  Gels were dried and then 
prehybridized in Church Mix (0.5M Na2HPO4 pH 7.2, 1 mM EDTA, 7% 
SDS, 1% BSA) for 1 hr. at 50°C.  Hybridization was performed overnight at 
50°C in Church Mix with 4 ng of a γ-32P-ATP end-labeled probe, 
[CCCTAA]4 (See below for labeling protocol).  The gel was washed at 
55°C: 3 times for 30 min. each in 4X SSC and one time for 30 min. in 4X 
SSC, 0.1% SDS and exposed to a PhosphorImager screen.  Subsequently, 
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the gel was denatured in 0.5 M NaOH, 1.5 M NaCl for 30 min., neutralized 
with two 15 minute washes in 0.5 M Tris-HCl pH 7.5, 3 M NaCl, 
prehybridized in Church mix for 1 hr. at 55°C, and hybridized with the same 
probe as above overnight at 55°C.  The gel was washed and exposed as 
above. 
Southern blot to detect telomeric DNA from human cells 
DNA was separated on a 0.7% agarose gel in 0.5X TBE with ethidium 
bromide by running for 1 hr. at 30 V and then running at 45V until the 
orange G front was at the bottom of the gel (approximately overnight). At 
this point the gel was photographed. The gel was then run until the 1.3 kb 
marker was almost at the bottom of the gel. The gel was photographed again 
with a ruler next to the markers.  Gel was gently shaken in Depurination 
solution (0.25 M HCl) for 30 min., twice in Denaturation solution (1.5 M 
NaCl; 0.5 M NaOH) for 30 min., and twice in Neutralization solution (1 M 
Trish pH 7.4, 1.5M NaCl) for 30 min. The DNA gel was then blotted onto a 
Hybond filter overnight in 20X SSC.  The membrane was cross-linked, 
rinsed in H20, and prehybridized and probed as in the in gel hybridization 
protocol above. 
Chromatin Immunoprecipitation (ChIP) 
Cells were trypsinized and washed with PBS, fixed in 1% formaldehyde in 
PBS for 60 min. at RT, washed in PBS, and lysed in 1% SDS, 50 mM Tris-
HCl pH 8.0, 10 mM EDTA at a density of 1x107 cells/ml.  Lysates were 
sonicated on ice for 10 cycles of 20 seconds each (0.5 seconds on/0.5 
seconds off) on power setting 5 on a Misonix Sonicator 3000.  Two 50 µl  
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aliquots of lysates were set aside at 4°C to represent “Total” DNA.  200 µl 
of lysate was diluted with 1.2 ml 0.01% SDS, 1.1% Triton X-100, 1.2 mM 
EDTA, 16.7 mM Tris-HCl pH 8.0, and 150 mM NaCl.  Antibody (20 µl 
crude serum or 4 µl affinity purified antibody or anti-c-myc 9E10, see 
antibody section below for specifics) was added and cells were nutated 
overnight at 4°C.  30 µl protein G sepharose beads (Amersham; blocked 
with 30 µg BSA and 5 µg sheared E. coli DNA) was added and samples 
were nutated for an additional 30 min. at 4°C.  Beads were pelleted by 
centrifugation and pellets were washed with 0.1% SDS, 1% Triton X-100, 2 
mM EDTA pH 8.0, 20 mM Tris-HCl pH 8.0, 150 mM NaCl.  The second 
wash was the same except with 500 mM NaCl.  Subsequent washes were 
with 0.25 M LiCl, 1% NP-40, 1% Na-deoxycholate, 1 mM EDTA pH 8.0, 
10 mM Tris-HCl pH 8.0, 1 mM EDTA.  Chromatin was eluted from beads 
with 500 µl 1% SDS, 0.1M Na2CO3.  450 µl 1% SDS, 0.1M Na2CO3 was 
added to the “Total” fractions, and these were subsequently processed along 
with the rest of the samples.  20 µl 5M NaCl was added and samples were 
incubated for 4 hr. at 65°C to reverse cross-links.  At this point, 20 µl 1M 
Tris-HCl pH 6.5, 10 µl 0.5 M EDTA, and 20 µg DNase free RNase A was 
added and samples were incubated at 37°C for 30 min.  40 µg proteinase K 
was added and samples were digested for 60 min. at 37°C and extracted with 
phenol.  20 µg of glycogen was added and samples were mixed.  1 ml 
ethanol was added and DNA was precipitated overnight at -20°C.  
Precipitated DNA was dissolved in 100 µl H20, denatured at 95°C for 5 
min., and blotted onto Hybond membranes in 2X SSC (0.3M NaCl, 0.03M 
Sodium citrate).  “Total” fractions were diluted 1/4, 1/8, and 1/16 and 
blotted as well.  Membranes were treated with 1.5M NaCl, 0.5 N NaOH for 
 
143 
10 min. and then with 1 M NaCl, 0.5 M Tris-HCl pH 7.0 for 10 min. 
Hybridization was performed with a γ32-P endlabeled [CCCTAA]4 probe as 
described for in gel hybridization of genomic DNA.  Membranes were 
washed 4 times in 2X SSC and exposed overnight to a PhosphorImager 
screen.  Screens were developed using a STORM 820 Phosphorimager 
(Molecular Dynamics).  ImageQuant software was used to quantify the 
percent of total telomeric DNA that was precipitated by each antibody. 
C Strand STELA 
Multiple ligation reactions were performed with individual C telorettes 
whereby 10 ng EcoRI-digested DNA was incubated in a 10 μl reaction (1× 
ligase buffer, 0.5 U T4 ligase, 10-2 to 10-5 μM of individual telorettes) at 
35°C for 12 hr. Mutiple amplification reactions were performed (26 cycles 
of 95°C for 15 s, 58°C for 20 s, and 68°C for 10 min) by using 1 U of 
FailSafe enzyme mix (Epicenter), 12.5 μl FailSafe buffer H (2×, provided 
by manufacturer), and 0.1 μM primers (XpYpE2 forward primer and Teltail 
reverse primer) in a final volume of 25 μL containing 200 pg/μL DNA. 
The amplification products were resolved on a 0.5% agarose gel, denatured, 
transferred onto a positively charged nylon membrane (Amersham), fixed 
with UV, and hybridized with a subtelomeric probe (generated by PCR 
using XpYpE2 and XpYpB2 and labeled by random priming). The 
membrane was exposed to a PhosphorImager screen and scanned. 




XpYpE2 (forward primer subtelomeric), 5′-TTGTCTCAGGGTCCTAGTG-
3′; XpYpB2 (reverse primer subtelomeric), 5′-
TCTGAAAGTGGACC(A/T)ATCAG-3′;  
C telorette 1, 5′-TGCTCCGTGCATCTGGCATCCCCTAAC-3′;  
C telorette 2, 5′-TGCTCCGTGCATCTGGCATCTAACCCT-3′;  
C telorette 3, 5′-TGCTCCGTGCATCTGGCATCCCTAACC-3′;  
C telorette 4, 5′-TGCTCCGTGCATCTGGCATCCTAACCC-3′;  
C telorette 5, 5′-TGCTCCGTGCATCTGGCATCAACCCTA-3′;  
C telorette 6, 5′-TGCTCCGTGCATCTGGCATCACCCTAA-3′;  
C teltail (reverse primer), 5′-TGCTCCGTGCATCTGGCATC-3′. 
T Circle Amplification 
1-3 μg of genomic DNA was digested with MboI and AluI and resuspended 
in an annealing buffer (0.2 M Tris [pH 7.5], 0.2 M KCl, and 1 mM EDTA) 
with 1 μM (CCCTAAA)3 primer containing thiophosphate linkages 
between the three 3′ terminal nucleotides. The mix was denatured at 96°C 
for 5 min and cooled down to 25°C for 2 hr. DNA was ethanol precipitated 
and resuspended in 20 μl of the TCA reaction buffer (33 mM Tris-acetate 
[pH 7.9], 10 mM magnesium acetate, 66 mM potassium acetate, 0.1% 
Tween 20, 1 mM DTT, and 0.37 mM dNTPs). Primer extension was carried 
out with 7.5 U of φ29 DNA polymerase (MBI Fermentas) at 30°C for 18 hr. 
The φ29 DNA polymerase was inactivated by incubation at 65°C for 20 min. 
The extension products were separated by denaturing gel electrophoresis 
(0.8% agarose, 50 mM NaOH, and 1 mM EDTA [pH 8]) at 2 V/cm for 18 
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hr, transferred onto a neutral nylon membrane, and hybridized using an [α-
32P]dCTP Klenow-labeled 800-bp telomeric DNA probe from pSP73Sty11 
{de Lange et al., 1990, Mol Cell Biol, 10, 518-27} {de Lange, 1992, Embo 
J, 11, 717-24}. Blots were exposed to PhosphorImager screens. 
γ-32P  end labeling of oligonucleotides with T4 polynucleotide kinase 
(PNK) 
2 µl H20, 1 µl 10X T4 DNA PNK buffer (NEB), 1 µl 10 U/µl T4 DNA PNK 
(NEB), 1 µl 50 ng/µl [CCCTAA]4 oligonucleotide and 5 µl 10.0 mCi/ml γ-
32P (NEN) were mixed and incubated for 45 min. at 37°C.  80 µl TES (10 
mM Tris-HCl pH 8.0, 10 mM EDTA pH 8.0, 0.01% SDS) were added to 
stop the reaction.  The probe was loaded onto a 3 ml G25 Sephadex column 
equilibrated with TNES (10 mM Tris-HCl pH 7.4, 10 mM EDTA, 100 mM 
NaCl, 1% SDS).  The column was washed with 700 µl TNES and the probe 
was eluted with 600 µl TNES. 
Apollo Antibodies 
Antibodies to KLH-conjugated Apollo peptides 
P1: (NH2-SRKIHSSHPDIHVIPYSDHSSYSC-COOH; starting at aa 258) 
and P2: (NH2-GDDDGGPEATGNQSAWMGHGSPLC; starting at aa 461)   
were generated in NZW rabbits (Covance). The resulting immune serum for 
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Western 1:1000 Zhu/de 
Lange lab 





p54 p54 Rb, 
poly 
Western 1:2000 Konarska 
Lab RU 
864 Tin2 Rb, 
poly 
Western 1:2000 Ye/ de 
Lange 





9E10 c-myc peptide Mo 
mono 
IF 1:5000 Sigma 
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ID antigen Type Applications  Origin 
M2 Flag peptide Mo 
mono 
Western 1:10,000 Sigma 


































DO-1 p53 Mo, 
mono 
Western 1:300 Santa Cruz 
GNS1 Cyclin B Mo, 
mono 





Western 1:5000 Sigma 
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Western 1:1000 Cell 
Signaling 
Chk2 Chk2 Mo, 
mono 
Western 1:300 BD 
Transductio
n Lab 
F-5 p21 mo, 
mono 
Western 1:500 Santa Cruz 
p16 human p16 mo, 
mono 
Western 1:100 NovaCastra 
α53BP1 Human 53BP1 Mo 
mono 







IF 1:1000 Novus 
1223 mPot1b Rb, 
poly 
Western 1:1000 Hockemeye
r/ de Lange 
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ID antigen Type Applications  Origin 




Western (m) 1:5000   Celli/de 
Lange  
979 hPot1 Rb, 
poly 
Western 1:1000 Loayza/ de 
Lange 
DBC-1 DBC-1 Rb, 
poly 
Western 1:1000 Bethyl Labs 
Coilin Coilin Mo, 
mono 
IF 1:1000 Sigma 
RuvBL2 Tip48 Rb, 
poly 
Western 1:200 Aviva 
polι polι Rb, 
poly 
Western 1:1000 Novus 
polη polη Rb, 
poly 
1:300 Santa Cruz 
PC-130 Rad51 Rb, 
poly 
Western 1:1000 Calbiochem 
Rad51C Rad51C Mo, Western 1:1000 Novus 
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ID antigen Type Applications  Origin 
mono 
ATRIP ATRIP Rb, 
poly 







Western 1:500 Santa Cruz 
Ab 476 WRN Rb, 
poly 
Western 1:1000 Novus 
Ab 200 BLM Rb, 
poly 
Western 1:1000 AbCam 
FANCD2 FANCD2 Rb, 
poly 
Western 1:1000 Auerbach, 
RU 
BRCA2 BRCA2 Rb, 
poly 
Western 1:1000 Novus 
H-152 Rad54 Rb, 
poly 
Western 1:100 Santa Cruz 
BRCA1 BRCA1 Mo, Western 1:100 Calbiochem 
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ID antigen Type Applications  Origin 
Ab-1 mono 
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